https://www.medxy.ai/news/zh/cpap-intervention-parkinsons-risk 2026-01-02T11:20:29.000Z daily 0.75 https://www.medxy.ai/news/global-vascular-dementia-criteria 2026-01-02T11:12:24.000Z daily 0.75 https://www.medxy.ai/news/zh/global-standards-vascular-dementia 2026-01-02T11:20:45.000Z daily 0.75 https://www.medxy.ai/news/ja/vascog-2-wso-diagnosis 2026-01-02T11:20:57.000Z daily 0.75 https://www.medxy.ai/news/precision-screening-p-tau217 2026-01-02T11:31:39.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-screening-alzheimer-ptau217 2026-01-02T11:31:48.000Z daily 0.75 https://www.medxy.ai/news/ja/preclinical-alzheimer-screening 2026-01-02T11:32:39.000Z daily 0.75 https://www.medxy.ai/news/zh/precise-alzheimer-screening 2026-01-02T11:32:25.000Z daily 0.75 https://www.medxy.ai/news/ambient-air-pollution-alzheimers 2026-01-02T11:37:01.000Z daily 0.75 https://www.medxy.ai/news/vi/air-pollution-alzheimers 2026-01-02T11:59:36.000Z daily 0.75 https://www.medxy.ai/news/ja/lungs-and-pollution 2026-01-02T11:59:46.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-lungs-air-pollution-alzheimers 2026-01-02T11:59:57.000Z daily 0.75 https://www.medxy.ai/news/circumferential-aneurysm-risk 2026-01-02T11:43:32.000Z daily 0.75 https://www.medxy.ai/news/vi/enhanced-arterial-wall-thinning-risk 2026-01-02T12:00:09.000Z daily 0.75 https://www.medxy.ai/news/ja/stroke-aneurysm-risk 2026-01-02T12:00:21.000Z daily 0.75 https://www.medxy.ai/news/zh/aortic-aneurysm-risk 2026-01-02T12:00:38.000Z daily 0.75 https://www.medxy.ai/news/guided-antiplatelet-de-escalation 2026-01-02T11:59:08.000Z daily 0.75 https://www.medxy.ai/news/vi/reducing-antiplatelet-dose-acs 2026-01-02T12:16:13.000Z daily 0.75 https://www.medxy.ai/news/zh/guideline-antiplatelet-therapy 2026-01-02T12:16:36.000Z daily 0.75 https://www.medxy.ai/news/dkk2-inhibition-neurovascular-strategy 2026-01-02T12:07:40.000Z daily 0.75 https://www.medxy.ai/news/vi/dkk2-inhibition-strategy 2026-01-02T12:16:43.000Z daily 0.75 https://www.medxy.ai/news/ja/dkk2-inhibition-neurovascular-strategy-2 2026-01-02T12:16:52.000Z daily 0.75 https://www.medxy.ai/news/zh/dkk2-suppression-new-strategy 2026-01-02T12:17:00.000Z daily 0.75 https://www.medxy.ai/news/high-risk-carotid-biomarkers 2026-01-02T12:14:53.000Z daily 0.75 https://www.medxy.ai/news/vi/narrow-artery-pressure-biomarkers 2026-01-03T15:25:08.000Z daily 0.75 https://www.medxy.ai/news/ja/narrowing-beyond-biomarkers 2026-01-03T15:25:21.000Z daily 0.75 https://www.medxy.ai/news/zh/key-biomarkers-for-carotid-plaque 2026-01-03T15:25:34.000Z daily 0.75 https://www.medxy.ai/news/reversible-cardiotoxicity-osimertinib 2026-01-03T15:25:41.000Z daily 0.75 https://www.medxy.ai/news/vi/osimertinib-heart-toxicity 2026-01-03T15:26:27.000Z daily 0.75 https://www.medxy.ai/news/ja/unraveling-osimertinib-cardiotoxicity 2026-01-03T15:26:19.000Z daily 0.75 https://www.medxy.ai/news/zh/gata4-mylk3-myl2-axis 2026-01-03T15:26:10.000Z daily 0.75 https://www.medxy.ai/news/oral-magnesium-heart-failure 2026-01-02T13:12:06.000Z daily 0.75 https://www.medxy.ai/news/vi/magnesium-supplement-heart-failure 2026-01-03T15:26:41.000Z daily 0.75 https://www.medxy.ai/news/ja/oral-magnesium-reduces-risk-2 2026-01-03T15:26:51.000Z daily 0.75 https://www.medxy.ai/news/zh/oral-magnesium-reduces-risk 2026-01-03T15:26:59.000Z daily 0.75 https://www.medxy.ai/news/awake-prone-covid-evidence 2026-01-03T15:27:19.000Z daily 0.75 https://www.medxy.ai/news/vi/covid-19-hypertension 2026-01-03T15:27:28.000Z daily 0.75 https://www.medxy.ai/news/zh/covid-19-proning-evidence 2026-01-03T15:27:47.000Z daily 0.75 https://www.medxy.ai/news/restoring-beat-sepsis-cardiomyopathy 2026-01-02T13:46:58.000Z daily 0.75 https://www.medxy.ai/news/vi/restore-heart-rhythm 2026-01-03T15:27:51.000Z daily 0.75 https://www.medxy.ai/news/ja/rhythm-recovery-errg-agonist 2026-01-03T15:27:58.000Z daily 0.75 https://www.medxy.ai/news/zh/restoring-heartbeat 2026-01-03T15:28:05.000Z daily 0.75 https://www.medxy.ai/news/pert-revolution-catheter-therapy 2026-01-02T16:23:57.000Z daily 0.75 https://www.medxy.ai/news/vi/pert-revolution-therapy-2 2026-01-03T15:28:09.000Z daily 0.75 https://www.medxy.ai/news/zh/pert-revolution 2026-01-03T15:28:21.000Z daily 0.75 https://www.medxy.ai/news/beyond-resting-state-exercise 2026-01-03T15:23:53.000Z daily 0.75 https://www.medxy.ai/news/vi/pulmonary-resistance-fontan 2026-01-03T15:28:25.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-rest-exercise-pvr 2026-01-03T15:28:32.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-baseline-exercise 2026-01-03T15:29:13.000Z daily 0.75 https://www.medxy.ai/news/jcad-cardiovascular-risk 2026-01-03T15:29:19.000Z daily 0.75 https://www.medxy.ai/news/vi/jcad-forecast-negative-cardiac-events 2026-01-03T15:33:32.000Z daily 0.75 https://www.medxy.ai/news/ja/jcad-predicts-malicious-cardiovascular-events 2026-01-03T15:33:40.000Z daily 0.75 https://www.medxy.ai/news/zh/jcad-acs-cardiovascular-events 2026-01-03T17:03:36.000Z daily 0.75 https://www.medxy.ai/news/parasternal-window-aortic-regurgitation 2026-01-03T17:00:40.000Z daily 0.75 https://www.medxy.ai/news/parasternal-window-standards 2026-01-03T17:03:46.000Z daily 0.75 https://www.medxy.ai/news/ja/why-sternum-window-aortic-regurgitation 2026-01-03T18:00:40.000Z daily 0.75 https://www.medxy.ai/news/zh/sternal-window-aortic-regurgitation 2026-01-03T18:00:50.000Z daily 0.75 https://www.medxy.ai/news/price-of-time-stemi-mortality 2026-01-03T17:14:35.000Z daily 0.75 https://www.medxy.ai/news/vi/value-of-time-stemi 2026-01-03T18:00:57.000Z daily 0.75 https://www.medxy.ai/news/ja/value-of-time 2026-01-03T18:01:06.000Z daily 0.75 https://www.medxy.ai/news/zh/time-value-stemi-death 2026-01-03T18:01:14.000Z daily 0.75 https://www.medxy.ai/news/universal-cholesterol-screening-age-one 2026-01-03T17:44:55.000Z daily 0.75 https://www.medxy.ai/news/vi/cholesterol-screening-age 2026-01-03T18:01:23.000Z daily 0.75 https://www.medxy.ai/news/ja/universal-cholesterol-screening-reasons 2026-01-03T18:01:30.000Z daily 0.75 https://www.medxy.ai/news/zh/cholesterol-screening-guidelines 2026-01-03T18:01:42.000Z daily 0.75 https://www.medxy.ai/news/high-risk-genotypes-heart-failure 2026-01-03T17:51:34.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-arrhythmia-high-risk-genes 2026-01-03T18:01:46.000Z daily 0.75 https://www.medxy.ai/news/ja/irregular-heartbeat-genetics 2026-01-03T18:01:55.000Z daily 0.75 https://www.medxy.ai/news/zh/arrhythmia-genotype-predictions 2026-01-03T18:02:02.000Z daily 0.75 https://www.medxy.ai/news/bailout-catheter-ablation 2026-01-03T18:00:27.000Z daily 0.75 https://www.medxy.ai/news/vi/catheter-ablation-strategy 2026-01-03T19:03:46.000Z daily 0.75 https://www.medxy.ai/news/ja/rescue-ablation-strategy-2 2026-01-03T19:03:57.000Z daily 0.75 https://www.medxy.ai/news/zh/rescue-ablation-strategy 2026-01-03T19:04:08.000Z daily 0.75 https://www.medxy.ai/news/beyond-mutation-dilated-cardiomyopathy 2026-01-03T18:35:18.000Z daily 0.75 https://www.medxy.ai/news/vi/sau-bien-doi-benh-tim-titin 2026-01-03T19:04:12.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-mutations-titin-cardiomyopathy 2026-01-03T19:04:21.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-mutations-titin-disease 2026-01-03T19:04:28.000Z daily 0.75 https://www.medxy.ai/news/hypertensive-response-conduction-disorders 2026-01-03T18:42:20.000Z daily 0.75 https://www.medxy.ai/news/vi/hypertension-reaction 2026-01-03T19:04:35.000Z daily 0.75 https://www.medxy.ai/news/ja/hypertension-response-paradox 2026-01-03T19:04:43.000Z daily 0.75 https://www.medxy.ai/news/zh/hypertension-response-in-advanced-conduction-disorders 2026-01-03T19:04:54.000Z daily 0.75 https://www.medxy.ai/news/ffr-revascularization-tavi-trial 2026-01-03T18:47:45.000Z daily 0.75 https://www.medxy.ai/news/vi/ffr-based-stratification-tavi 2026-01-03T19:04:58.000Z daily 0.75 https://www.medxy.ai/news/ja/faitavi-trial-ffr-revascularization-macce 2026-01-03T19:05:07.000Z daily 0.75 https://www.medxy.ai/news/zh/ffr-guided-tavi-macce 2026-01-03T19:05:14.000Z daily 0.75 https://www.medxy.ai/news/cpvt-risk-assessment 2026-01-03T19:05:45.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-risk-assessment 2026-01-03T22:36:21.000Z daily 0.75 https://www.medxy.ai/news/ja/cpvt-risk-assessment-2 2026-01-03T22:36:27.000Z daily 0.75 https://www.medxy.ai/news/zh/cpvt-risk-assessment-3 2026-01-03T22:36:33.000Z daily 0.75 https://www.medxy.ai/news/m-teer-benefits-mitral-regurgitation 2026-01-03T20:00:13.000Z daily 0.75 https://www.medxy.ai/news/vi/m-teer-benefits-hf 2026-01-03T22:36:38.000Z daily 0.75 https://www.medxy.ai/news/ja/m-teer-impact-on-aortic-reflux 2026-01-03T22:36:44.000Z daily 0.75 https://www.medxy.ai/news/zh/m-teer-mitral-regurgitation-benefits 2026-01-03T22:36:50.000Z daily 0.75 https://www.medxy.ai/news/subcutaneous-icds-honest-study 2026-01-03T20:10:23.000Z daily 0.75 https://www.medxy.ai/news/vi/icd-duoi-da-honest-france 2026-01-03T22:36:58.000Z daily 0.75 https://www.medxy.ai/news/zh/subcutaneous-cardiac-defibrillator 2026-01-03T22:37:23.000Z daily 0.75 https://www.medxy.ai/news/high-acuity-cardial-outcomes 2026-01-03T20:29:56.000Z daily 0.75 https://www.medxy.ai/news/vi/young-patient-contradictions-cardiology 2026-01-03T22:37:28.000Z daily 0.75 https://www.medxy.ai/news/ja/high-acuity-outcomes-paradox 2026-01-03T22:37:40.000Z daily 0.75 https://www.medxy.ai/news/zh/high-acuity-outcomes 2026-01-03T22:37:56.000Z daily 0.75 https://www.medxy.ai/news/30-day-ischemic-penalty 2026-01-03T21:41:07.000Z daily 0.75 https://www.medxy.ai/news/vi/blood-thinning-risk 2026-01-03T22:38:00.000Z daily 0.75 https://www.medxy.ai/news/ja/30-day-ischemia-penalty 2026-01-03T22:38:09.000Z daily 0.75 https://www.medxy.ai/news/zh/30-day-ischemia-warning 2026-01-03T22:38:17.000Z daily 0.75 https://www.medxy.ai/news/baseline-risk-pci-benefit 2026-01-03T21:56:05.000Z daily 0.75 https://www.medxy.ai/news/vi/basic-risk-pci-benefits 2026-01-03T22:38:22.000Z daily 0.75 https://www.medxy.ai/news/ja/pci-effect-ischemic-heart-failure 2026-01-03T22:38:31.000Z daily 0.75 https://www.medxy.ai/news/zh/baseline-risk-ischaemic-heart-disease 2026-01-03T22:38:38.000Z daily 0.75 https://www.medxy.ai/news/timing-matters-lipid-risk 2026-01-03T22:25:46.000Z daily 0.75 https://www.medxy.ai/news/vi/important-time-statins-heart-attack 2026-01-03T22:38:48.000Z daily 0.75 https://www.medxy.ai/news/ja/timing-is-crucial 2026-01-03T22:39:01.000Z daily 0.75 https://www.medxy.ai/news/zh/crucial-timing-in-statin-use 2026-01-03T22:39:12.000Z daily 0.75 https://www.medxy.ai/news/win-ratio-analysis-anticoagulation 2026-01-03T22:35:47.000Z daily 0.75 https://www.medxy.ai/news/vi/win-rate-analysis-anticoagulation-atrial-fibrillation 2026-01-03T22:39:47.000Z daily 0.75 https://www.medxy.ai/news/ja/winning-rate-analysis-atrial-fibrillation 2026-01-04T15:40:48.000Z daily 0.75 https://www.medxy.ai/news/zh/win-rate-analysis-afib-anticoagulation 2026-01-04T15:40:55.000Z daily 0.75 https://www.medxy.ai/news/mental-health-labels-stemi-mortality 2026-01-03T22:49:06.000Z daily 0.75 https://www.medxy.ai/news/vi/mental-health-labels-stemi 2026-01-04T15:41:05.000Z daily 0.75 https://www.medxy.ai/news/ja/mental-health-labels-and-heart-attack-risk 2026-01-04T15:41:14.000Z daily 0.75 https://www.medxy.ai/news/zh/psychological-health-delays 2026-01-04T15:41:22.000Z daily 0.75 https://www.medxy.ai/news/cmr-ecv-mapping-amyloid-stabilization 2026-01-03T23:08:20.000Z daily 0.75 https://www.medxy.ai/news/vi/invisible-tracking-predictions 2026-01-04T15:41:30.000Z daily 0.75 https://www.medxy.ai/news/ja/invisible-tracking-patisiran-2 2026-01-04T15:41:40.000Z daily 0.75 https://www.medxy.ai/news/zh/invisible-tracking-patisiran 2026-01-04T15:41:48.000Z daily 0.75 https://www.medxy.ai/news/elevated-ldl-c-risk 2026-01-03T23:20:25.000Z daily 0.75 https://www.medxy.ai/news/vi/ldl-c-tang-nguy-co-tim-mach 2026-01-04T15:41:56.000Z daily 0.75 https://www.medxy.ai/news/ja/zero-calcification-ldl-cardiovascular-risk 2026-01-04T15:42:05.000Z daily 0.75 https://www.medxy.ai/news/zh/ldl-c-increases-cardiovascular-risk 2026-01-04T15:42:14.000Z daily 0.75 https://www.medxy.ai/news/beyond-bmi-fat-distribution 2026-01-03T23:47:05.000Z daily 0.75 https://www.medxy.ai/news/vi/body-fat-distribution-by-gender 2026-01-04T15:42:23.000Z daily 0.75 https://www.medxy.ai/news/ja/bmi-and-fat-distribution 2026-01-04T15:42:31.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-bmi-fat-distribution-2 2026-01-04T15:42:42.000Z daily 0.75 https://www.medxy.ai/news/ai-oct-analysis-outscores-experts 2026-01-03T23:53:43.000Z daily 0.75 https://www.medxy.ai/news/vi/oct-ai-analysis 2026-01-04T15:42:46.000Z daily 0.75 https://www.medxy.ai/news/ja/oct-analysis-ai-superior 2026-01-04T15:42:55.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-oct-analysis-insights 2026-01-04T15:43:02.000Z daily 0.75 https://www.medxy.ai/news/nsaid-co-prescription-atrial-fibrillation 2026-01-04T15:40:23.000Z daily 0.75 https://www.medxy.ai/news/female-sex-stroke-risk 2026-01-04T18:10:10.000Z daily 0.75 https://www.medxy.ai/news/vi/female-sex-stroke-risk-2 2026-01-04T18:14:31.000Z daily 0.75 https://www.medxy.ai/news/ja/female-stroke-risk-afib 2026-01-04T18:14:42.000Z daily 0.75 https://www.medxy.ai/news/zh/female-sex-risk-afib-stroke 2026-01-05T00:51:59.000Z daily 0.75 https://www.medxy.ai/news/semaglutide-survival-type-2-diabetes 2026-01-04T22:12:30.000Z daily 0.75 https://www.medxy.ai/news/vi/semaglutide-extends-lifespan-diabetes 2026-01-05T00:52:06.000Z daily 0.75 https://www.medxy.ai/news/ja/semaglutide-extends-survival-non-obese-type-2-diabetes 2026-01-05T19:54:23.000Z daily 0.75 https://www.medxy.ai/news/zh/semaglutide-extends-lifespan 2026-01-05T19:54:29.000Z daily 0.75 https://www.medxy.ai/news/persistent-chest-pain-women 2026-01-04T23:54:31.000Z daily 0.75 https://www.medxy.ai/news/vi/burden-on-women-chest-pain 2026-01-05T19:54:11.000Z daily 0.75 https://www.medxy.ai/news/ja/chest-pain-in-women 2026-01-05T19:53:59.000Z daily 0.75 https://www.medxy.ai/news/zh/women-chest-pain-cardiac-burden 2026-01-05T19:53:44.000Z daily 0.75 https://www.medxy.ai/news/new-benchmarking-standard-risk-models 2026-01-05T10:14:52.000Z daily 0.75 https://www.medxy.ai/news/vi/new-evaluation-standards-risk-models 2026-01-05T19:53:28.000Z daily 0.75 https://www.medxy.ai/news/ja/new-standards-cardiac-arrest-rosc-model 2026-01-05T19:53:20.000Z daily 0.75 https://www.medxy.ai/news/elevated-d-dimer-predictor 2026-01-05T10:21:39.000Z daily 0.75 https://www.medxy.ai/news/zh/new-benchmark-out-of-hospital-cardiac-arrest-model 2026-01-05T19:53:07.000Z daily 0.75 https://www.medxy.ai/news/vi/high-d-dimer-hospital-mortality 2026-01-05T19:52:46.000Z daily 0.75 https://www.medxy.ai/news/ja/d-dimer-takotsubo-mortality 2026-01-05T19:52:36.000Z daily 0.75 https://www.medxy.ai/news/zh/d-dimer-elevation-hospitalization 2026-01-05T19:52:28.000Z daily 0.75 https://www.medxy.ai/news/high-sensitivity-crp-risk 2026-01-05T11:06:45.000Z daily 0.75 https://www.medxy.ai/news/vi/high-sensitivity-crp-cardiac-risk 2026-01-05T19:52:13.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-standard-risk-factors 2026-01-05T19:52:04.000Z daily 0.75 https://www.medxy.ai/news/zh/high-sensitivity-crp-cardiovascular-risk 2026-01-05T19:51:56.000Z daily 0.75 https://www.medxy.ai/news/ideal-cardiovascular-health 2026-01-05T12:12:35.000Z daily 0.75 https://www.medxy.ai/news/vi/cardiovascular-health-ideal 2026-01-05T19:51:20.000Z daily 0.75 https://www.medxy.ai/news/ja/ideal-cardiovascular-health-score 2026-01-05T19:51:32.000Z daily 0.75 https://www.medxy.ai/news/zh/ideal-cardiovascular-health-2 2026-01-05T19:51:42.000Z daily 0.75 https://www.medxy.ai/news/safety-apixaban-rivaroxaban 2026-01-05T12:25:22.000Z daily 0.75 https://www.medxy.ai/news/glide-score-predictor 2026-01-05T13:22:53.000Z daily 0.75 https://www.medxy.ai/news/vi/glide-score-predicts-success-2 2026-01-05T19:50:53.000Z daily 0.75 https://www.medxy.ai/news/ja/glide-score-transcatheter-success 2026-01-05T19:51:02.000Z daily 0.75 https://www.medxy.ai/news/zh/glide-score-predicts-success 2026-01-05T19:51:11.000Z daily 0.75 https://www.medxy.ai/news/a-new-frontier-fabry-risk 2026-01-05T17:51:09.000Z daily 0.75 https://www.medxy.ai/news/metabolomics-polygenic-scores 2026-01-05T17:54:00.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-risk-prediction 2026-01-05T19:50:40.000Z daily 0.75 https://www.medxy.ai/news/ja/metabolomics-genetic-scores 2026-01-05T19:50:36.000Z daily 0.75 https://www.medxy.ai/news/zh/metabolomics-genetic-scores-2 2026-01-05T19:50:27.000Z daily 0.75 https://www.medxy.ai/news/normal-t1-mapping-fabry-score 2026-01-05T18:06:49.000Z daily 0.75 https://www.medxy.ai/news/vi/t1-value-excluding-adverse-cardiac-events 2026-01-05T19:50:08.000Z daily 0.75 https://www.medxy.ai/news/zh/normal-t1-value-exclusion-cardiomyopathy 2026-01-05T19:50:16.000Z daily 0.75 https://www.medxy.ai/news/molecular-profiling-heart-rejection 2026-01-05T19:45:13.000Z daily 0.75 https://www.medxy.ai/news/vi/molecular-analysis-formalin-biopsies 2026-01-05T19:54:48.000Z daily 0.75 https://www.medxy.ai/news/ja/molecular-profiling-biopsy 2026-01-05T19:54:57.000Z daily 0.75 https://www.medxy.ai/news/zh/formalin-biopsy-molecular-profile 2026-01-05T19:55:06.000Z daily 0.75 https://www.medxy.ai/news/inflammatory-biomarkers-vte-risks 2026-01-05T19:55:23.000Z daily 0.75 https://www.medxy.ai/news/vi/biomarkers-vte-risk 2026-01-05T20:23:21.000Z daily 0.75 https://www.medxy.ai/news/ja/inflammation-cardiac-biomarkers-vte-risk-2 2026-01-05T20:23:37.000Z daily 0.75 https://www.medxy.ai/news/zh/inflammation-cardiac-biomarkers-vte-risk 2026-01-05T20:23:54.000Z daily 0.75 https://www.medxy.ai/news/lowering-blood-pressure 2026-01-05T20:01:43.000Z daily 0.75 https://www.medxy.ai/news/vi/lowering-blood-pressure-2 2026-01-05T20:24:06.000Z daily 0.75 https://www.medxy.ai/news/ja/blood-pressure-reduction-evidence 2026-01-05T20:24:18.000Z daily 0.75 https://www.medxy.ai/news/zh/lowering-dbp-hypertension-risk 2026-01-05T20:24:28.000Z daily 0.75 https://www.medxy.ai/news/metabolomics-polygenics-score2 2026-01-05T20:18:03.000Z daily 0.75 https://www.medxy.ai/news/vi/metabolomics-polygenics-score2-2 2026-01-05T20:24:40.000Z daily 0.75 https://www.medxy.ai/news/ja/metabolomics-score-integration 2026-01-05T20:24:55.000Z daily 0.75 https://www.medxy.ai/news/zh/metabolomics-genomics-score2 2026-01-05T20:25:03.000Z daily 0.75 https://www.medxy.ai/news/low-potassium-af-risk 2026-01-05T20:25:14.000Z daily 0.75 https://www.medxy.ai/news/vi/low-potassium-afib-risk-2 2026-01-05T20:34:24.000Z daily 0.75 https://www.medxy.ai/news/ja/low-potassium-af-risk-2 2026-01-05T20:34:34.000Z daily 0.75 https://www.medxy.ai/news/zh/low-potassium-afib-risk 2026-01-05T20:34:44.000Z daily 0.75 https://www.medxy.ai/news/neuroimaging-signatures-brain-lesions 2026-01-05T20:34:56.000Z daily 0.75 https://www.medxy.ai/news/vi/brain-image-features-differentiation 2026-01-05T21:05:33.000Z daily 0.75 https://www.medxy.ai/news/ja/different-cerebrovascular-patterns 2026-01-05T21:05:22.000Z daily 0.75 https://www.medxy.ai/news/zh/different-neuroimaging-features 2026-01-05T21:03:29.000Z daily 0.75 https://www.medxy.ai/news/immunotherapy-challenges-prostate-cancer 2026-01-05T21:03:16.000Z daily 0.75 https://www.medxy.ai/news/vi/immunotherapy-challenges-prostate-cancer-2 2026-01-05T21:03:08.000Z daily 0.75 https://www.medxy.ai/news/ja/immune-therapy-challenges-prostate-cancer 2026-01-05T21:02:59.000Z daily 0.75 https://www.medxy.ai/news/zh/metastatic-castration-resistant-prostate-cancer-immunotherapy-challenges 2026-01-05T21:02:50.000Z daily 0.75 https://www.medxy.ai/news/tailoring-axillary-surgery 2026-01-05T21:02:35.000Z daily 0.75 https://www.medxy.ai/news/vi/surgical-adjustment-axilla 2026-01-05T21:06:41.000Z daily 0.75 https://www.medxy.ai/news/ja/axillary-surgery-adjustments 2026-01-05T21:06:58.000Z daily 0.75 https://www.medxy.ai/news/zh/custom-armpit-surgery 2026-01-06T10:57:03.000Z daily 0.75 https://www.medxy.ai/news/temozolomide-idh-astrocytoma-survival 2026-01-05T21:08:50.000Z daily 0.75 https://www.medxy.ai/news/vi/temozolomide-astraglioma-idh 2026-01-06T07:38:24.000Z daily 0.75 https://www.medxy.ai/news/ja/idh-mutant-astrocytoma-temozolomide 2026-01-06T10:57:28.000Z daily 0.75 https://www.medxy.ai/news/zh/idh-mutant-astrocytoma-treatment 2026-01-06T10:57:19.000Z daily 0.75 https://www.medxy.ai/news/molecular-adjuvant-therapy-endometrial-cancer 2026-01-06T09:53:08.000Z daily 0.75 https://www.medxy.ai/news/dual-checkpoint-inhibition 2026-01-06T10:54:14.000Z daily 0.75 https://www.medxy.ai/news/vi/dual-checkpoint-activation 2026-01-06T10:57:43.000Z daily 0.75 https://www.medxy.ai/news/ja/double-checkpoint-inhibition-tiragolumab-atezolizumab 2026-01-06T11:01:32.000Z daily 0.75 https://www.medxy.ai/news/zh/double-checkpoint-inhibition 2026-01-06T11:01:40.000Z daily 0.75 https://www.medxy.ai/news/triple-drug-regimen-esophageal-cancer 2026-01-06T11:01:46.000Z daily 0.75 https://www.medxy.ai/news/vi/tiragolumab-atezolizumab-esophageal-cancer-2 2026-01-06T11:31:58.000Z daily 0.75 https://www.medxy.ai/news/ja/tiragolumab-atezolizumab-esophageal-cancer-3 2026-01-06T11:32:05.000Z daily 0.75 https://www.medxy.ai/news/zh/tiragolumab-atezolizumab-esophageal-cancer 2026-01-06T11:32:12.000Z daily 0.75 https://www.medxy.ai/news/toripalimab-advanced-acral-melanoma 2026-01-06T11:32:31.000Z daily 0.75 https://www.medxy.ai/news/vi/toripalimab-melanoma-treatment 2026-01-06T11:32:27.000Z daily 0.75 https://www.medxy.ai/news/ja/tripalumab-melanoma-treatment 2026-01-06T11:32:36.000Z daily 0.75 https://www.medxy.ai/news/zh/new-standard-melanoma-treatment 2026-01-06T11:32:41.000Z daily 0.75 https://www.medxy.ai/news/genetic-risk-rowing 2026-01-06T11:23:12.000Z daily 0.75 https://www.medxy.ai/news/vi/genetics-and-elite-rowing 2026-01-06T11:32:47.000Z daily 0.75 https://www.medxy.ai/news/ja/genetic-factors-elite-lawyers 2026-01-06T11:33:55.000Z daily 0.75 https://www.medxy.ai/news/zh/genetic-susceptibility-rowing-risks 2026-01-06T11:35:03.000Z daily 0.75 https://www.medxy.ai/news/beyond-the-virus-pediatric-long-covid 2026-01-06T11:35:25.000Z daily 0.75 https://www.medxy.ai/news/vi/beyond-virus-long-covid-risks 2026-01-06T13:17:01.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-viruses-sociocultural-factors 2026-01-06T13:16:49.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-viruses-child-long-covid-risk 2026-01-06T13:16:39.000Z daily 0.75 https://www.medxy.ai/news/digital-phenotyping-insomnia 2026-01-06T11:45:06.000Z daily 0.75 https://www.medxy.ai/news/vi/digital-phenotyping-insomnia-2 2026-01-06T13:16:26.000Z daily 0.75 https://www.medxy.ai/news/ja/insomnia-digital-expression 2026-01-06T13:16:14.000Z daily 0.75 https://www.medxy.ai/news/zh/insomnia-digital-phenotype 2026-01-06T13:16:06.000Z daily 0.75 https://www.medxy.ai/news/omega-3-pediatric-depression 2026-01-06T13:09:56.000Z daily 0.75 https://www.medxy.ai/news/vi/omega-3-trial-insights 2026-01-06T13:15:54.000Z daily 0.75 https://www.medxy.ai/news/ja/omega-3-supplement-study 2026-01-06T13:15:44.000Z daily 0.75 https://www.medxy.ai/news/zh/omega-3-supplements-depression 2026-01-06T13:15:33.000Z daily 0.75 https://www.medxy.ai/news/neuropsychiatric-vascular-health-ptsd 2026-01-06T13:19:16.000Z daily 0.75 https://www.medxy.ai/news/vi/nervous-spirit-interaction-cardiovascular-health 2026-01-06T13:19:27.000Z daily 0.75 https://www.medxy.ai/news/ja/nervous-system-cardiovascular-interaction 2026-01-06T13:19:34.000Z daily 0.75 https://www.medxy.ai/news/zh/neuropsychiatric-vascular-interaction 2026-01-06T13:19:40.000Z daily 0.75 https://www.medxy.ai/news/beyond-picky-eating-2 2026-01-06T13:21:57.000Z daily 0.75 https://www.medxy.ai/news/vi/ken-an-nghien-cuu-di-truyen 2026-01-06T13:24:11.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-pickydining 2026-01-06T13:24:18.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-picky-eating 2026-01-06T13:24:27.000Z daily 0.75 https://www.medxy.ai/news/risk-based-contracting-limits 2026-01-06T13:46:02.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-based-contracts-medicare-advantage 2026-01-06T13:46:09.000Z daily 0.75 https://www.medxy.ai/news/ja/risks-of-medicare-advantage 2026-01-06T13:46:13.000Z daily 0.75 https://www.medxy.ai/news/zh/risk-contract-limitations 2026-01-06T13:46:18.000Z daily 0.75 https://www.medxy.ai/news/child-abuse-trends 2026-01-06T13:31:47.000Z daily 0.75 https://www.medxy.ai/news/vi/national-trends-child-abuse 2026-01-06T13:46:34.000Z daily 0.75 https://www.medxy.ai/news/ja/child-abuse-trends-2 2026-01-06T13:46:41.000Z daily 0.75 https://www.medxy.ai/news/zh/child-abuse-trends-3 2026-01-06T13:46:45.000Z daily 0.75 https://www.medxy.ai/news/early-postpartum-bp-optimization 2026-01-06T13:41:45.000Z daily 0.75 https://www.medxy.ai/news/vi/postpartum-blood-pressure-insights 2026-01-06T13:46:55.000Z daily 0.75 https://www.medxy.ai/news/ja/blood-pressure-optimization 2026-01-06T13:51:30.000Z daily 0.75 https://www.medxy.ai/news/zh/early-postpartum-blood-pressure-optimization 2026-01-06T13:51:39.000Z daily 0.75 https://www.medxy.ai/news/age-adjusted-d-dimer-dvt 2026-01-06T13:47:15.000Z daily 0.75 https://www.medxy.ai/news/vi/d-dimer-age-thresholds 2026-01-06T13:51:58.000Z daily 0.75 https://www.medxy.ai/news/ja/adjust-dvt-dimer-cuts 2026-01-06T13:52:24.000Z daily 0.75 https://www.medxy.ai/news/zh/age-adjusted-d-dimer-threshold 2026-01-06T13:54:33.000Z daily 0.75 https://www.medxy.ai/news/multicomponent-nudges-influenza-vaccination 2026-01-06T13:53:52.000Z daily 0.75 https://www.medxy.ai/news/vi/multicomponent-approaches-flu-vaccination 2026-01-06T13:58:26.000Z daily 0.75 https://www.medxy.ai/news/ja/multi-component-intervention-influenza-vaccine 2026-01-06T17:23:26.000Z daily 0.75 https://www.medxy.ai/news/zh/multi-component-intervention-influenza-vaccination 2026-01-06T17:23:36.000Z daily 0.75 https://www.medxy.ai/news/neoadjuvant-therapy-outcomes 2026-01-06T17:27:48.000Z daily 0.75 https://www.medxy.ai/news/vi/chemoradiotherapy-vs-surgery-escc 2026-01-06T17:32:27.000Z daily 0.75 https://www.medxy.ai/news/ja/esophageal-cancer-treatment-comparison 2026-01-06T17:50:15.000Z daily 0.75 https://www.medxy.ai/news/zh/neoadjuvant-vs-adjuvant-esophageal-cancer 2026-01-06T17:50:43.000Z daily 0.75 https://www.medxy.ai/news/precision-prognosis-head-neck-cancer 2026-01-06T17:51:34.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-diagnosis-cancer-navigation 2026-01-06T17:51:46.000Z daily 0.75 https://www.medxy.ai/news/ja/precision-outcome-prediction 2026-01-06T17:52:00.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-outcomes-personalized-navigation-head-neck-cancer 2026-01-06T17:52:13.000Z daily 0.75 https://www.medxy.ai/news/rethinking-knee-hoffas-fat-pad 2026-01-06T17:52:26.000Z daily 0.75 https://www.medxy.ai/news/culturally-tailored-health-support 2026-01-06T18:05:28.000Z daily 0.75 https://www.medxy.ai/news/vi/culturally-tailored-support-weight-loss 2026-01-06T18:03:43.000Z daily 0.75 https://www.medxy.ai/news/ja/culturally-adapted-support 2026-01-06T18:05:52.000Z daily 0.75 https://www.medxy.ai/news/zh/community-health-support-hispanic-dialysis 2026-01-06T18:06:00.000Z daily 0.75 https://www.medxy.ai/news/ischemia-score-epilepsy 2026-01-06T18:24:19.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-classification-enhancement 2026-01-06T18:30:40.000Z daily 0.75 https://www.medxy.ai/news/ja/risk-classification-ischemia-score 2026-01-06T18:31:50.000Z daily 0.75 https://www.medxy.ai/news/zh/optimized-risk-stratification 2026-01-06T18:43:05.000Z daily 0.75 https://www.medxy.ai/news/cardiovascular-risk-anti-amyloid 2026-01-06T18:32:36.000Z daily 0.75 https://www.medxy.ai/news/vi/cardiovascular-event-risks 2026-01-06T18:43:12.000Z daily 0.75 https://www.medxy.ai/news/ja/cognitive-disorder-cardiovascular-risk 2026-01-06T18:43:24.000Z daily 0.75 https://www.medxy.ai/news/zh/cognitive-impairment-cardiovascular-risk 2026-01-06T18:43:32.000Z daily 0.75 https://www.medxy.ai/news/midlife-gfap-sentinel-cerebral-disease 2026-01-06T18:44:07.000Z daily 0.75 https://www.medxy.ai/news/vi/gfap-blood-marker-stroke 2026-01-06T19:09:29.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-sentinel-cerebral-small-vessel-disease 2026-01-06T19:09:42.000Z daily 0.75 https://www.medxy.ai/news/zh/plasma-gfap-sentinel 2026-01-06T19:09:51.000Z daily 0.75 https://www.medxy.ai/news/emergent-carotid-stenting 2026-01-06T19:05:10.000Z daily 0.75 https://www.medxy.ai/news/vi/stent-in-stroke-results 2026-01-06T19:10:03.000Z daily 0.75 https://www.medxy.ai/news/ja/emergency-carotid-stenting-outcomes 2026-01-06T19:11:28.000Z daily 0.75 https://www.medxy.ai/news/zh/ceres-tandem-study-outcomes 2026-01-06T19:11:36.000Z daily 0.75 https://www.medxy.ai/news/vi/carotid-stenting-thrombectomy 2026-01-06T19:12:08.000Z daily 0.75 https://www.medxy.ai/news/ja/emergency-carotid-stenting 2026-01-06T19:33:37.000Z daily 0.75 https://www.medxy.ai/news/zh/ceres-tandem-study 2026-01-06T19:33:49.000Z daily 0.75 https://www.medxy.ai/news/emergent-carotid-stenting-outcomes 2026-01-06T19:12:15.000Z daily 0.75 https://www.medxy.ai/news/vi/nong-stenting-stroke-outcomes 2026-01-06T19:34:03.000Z daily 0.75 https://www.medxy.ai/news/ja/emergency-carotid-stenting-results 2026-01-06T19:34:18.000Z daily 0.75 https://www.medxy.ai/news/zh/superior-results-carotid-stenting 2026-01-06T19:34:28.000Z daily 0.75 https://www.medxy.ai/news/age-sex-amyloid-tau-transition 2026-01-06T19:35:36.000Z daily 0.75 https://www.medxy.ai/news/albiglutide-cardiovascular-benefits 2026-01-06T19:36:06.000Z daily 0.75 https://www.medxy.ai/news/medical-management-vs-endovascular 2026-01-06T20:29:31.000Z daily 0.75 https://www.medxy.ai/news/vi/health-management-stroke 2026-01-07T00:35:02.000Z daily 0.75 https://www.medxy.ai/news/zh/drug-treatment-efficacy 2026-01-07T00:35:15.000Z daily 0.75 https://www.medxy.ai/news/glp-1-agents-subarachnoid-hemorrhage 2026-01-07T00:23:26.000Z daily 0.75 https://www.medxy.ai/news/vi/glp-1-receptor-stimulants-bleeding-risk 2026-01-07T00:35:23.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-agonist-and-subarachnoid-bleeding 2026-01-07T00:35:33.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-receptor-agents-subarachnoid-hemorrhage-risk 2026-01-07T00:35:43.000Z daily 0.75 https://www.medxy.ai/news/hidden-burden-heart-brain-health 2026-01-07T08:14:06.000Z daily 0.75 https://www.medxy.ai/news/vi/ascvd-and-suicide-risk 2026-01-07T11:02:10.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-brain-burden-ascvd 2026-01-07T11:02:25.000Z daily 0.75 https://www.medxy.ai/news/zh/heart-brain-health-burden 2026-01-07T11:02:35.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-cardiovascular-protection 2026-01-07T08:50:13.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibitors-cardiovascular-protection-2 2026-01-07T11:02:41.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-cardiovascular-protection-3 2026-01-07T11:02:52.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-cardiovascular-protection-4 2026-01-07T11:02:58.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-cardioprotection 2026-01-07T10:57:55.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-heart-protection-2 2026-01-07T11:03:37.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-heart-protection 2026-01-07T11:04:09.000Z daily 0.75 https://www.medxy.ai/news/oligodendrocyte-glycoprotein-neurodegeneration 2026-01-07T11:07:40.000Z daily 0.75 https://www.medxy.ai/news/vi/glycoprotein-myelin-oligodendrocytes 2026-01-07T11:42:57.000Z daily 0.75 https://www.medxy.ai/news/ja/oligodendrocyte-myelining-recovery 2026-01-07T11:43:03.000Z daily 0.75 https://www.medxy.ai/news/zh/oligodendrocyte-myelin-proteins 2026-01-07T11:43:11.000Z daily 0.75 https://www.medxy.ai/news/42-hour-window-dual-antiplatelet 2026-01-07T11:37:39.000Z daily 0.75 https://www.medxy.ai/news/vi/window-42-hours 2026-01-07T11:43:20.000Z daily 0.75 https://www.medxy.ai/news/ja/42-hour-window-stroke-impact 2026-01-07T11:43:29.000Z daily 0.75 https://www.medxy.ai/news/zh/42-hour-window-platelet-therapy 2026-01-07T11:43:42.000Z daily 0.75 https://www.medxy.ai/news/active-cancer-stroke-risks 2026-01-07T11:44:31.000Z daily 0.75 https://www.medxy.ai/news/vi/cancer-anemia-stroke-dapt 2026-01-07T13:27:33.000Z daily 0.75 https://www.medxy.ai/news/ja/cancer-dapt-stroke-risks 2026-01-07T13:27:57.000Z daily 0.75 https://www.medxy.ai/news/zh/increased-risk-of-ischemia-and-bleeding 2026-01-07T13:28:04.000Z daily 0.75 https://www.medxy.ai/news/post-tia-depression 2026-01-07T11:54:32.000Z daily 0.75 https://www.medxy.ai/news/vi/post-stroke-depression 2026-01-07T13:28:43.000Z daily 0.75 https://www.medxy.ai/news/ja/tia-depression-silent-indicator 2026-01-07T13:28:17.000Z daily 0.75 https://www.medxy.ai/news/zh/post-tia-depression-predictors 2026-01-07T13:28:24.000Z daily 0.75 https://www.medxy.ai/news/dexmedetomidine-cardiac-surgery-results 2026-01-07T12:03:27.000Z daily 0.75 https://www.medxy.ai/news/vi/dexmedetomidine-surgery-complications 2026-01-07T13:28:29.000Z daily 0.75 https://www.medxy.ai/news/ja/periopeartive-dexamethasone-study 2026-01-07T13:29:08.000Z daily 0.75 https://www.medxy.ai/news/zh/dexamethasone-heart-surgery-complications 2026-01-07T13:29:19.000Z daily 0.75 https://www.medxy.ai/news/diabetes-subtyping-predicts-comorbidities 2026-01-07T12:25:02.000Z daily 0.75 https://www.medxy.ai/news/vi/hba1c-diabetes-classification 2026-01-07T13:29:27.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-hba1c-diabetes-subtypes-2 2026-01-07T13:29:33.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-hba1c-diabetes-subtypes 2026-01-07T13:29:39.000Z daily 0.75 https://www.medxy.ai/news/angptl3-rnai-lowering-ldl-c 2026-01-07T12:53:05.000Z daily 0.75 https://www.medxy.ai/news/vi/rna-targeted-treatment-angptl3 2026-01-07T13:29:45.000Z daily 0.75 https://www.medxy.ai/news/ja/zodasiran-angptl3-rnai 2026-01-07T13:29:53.000Z daily 0.75 https://www.medxy.ai/news/zh/zodasiran-reduces-ldl-c 2026-01-07T13:30:00.000Z daily 0.75 https://www.medxy.ai/news/reversing-prediabetes-risk 2026-01-07T13:06:30.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-drug-heart-risk 2026-01-07T13:30:06.000Z daily 0.75 https://www.medxy.ai/news/ja/reverse-prediabetes-risks 2026-01-07T13:30:17.000Z daily 0.75 https://www.medxy.ai/news/zh/reversing-pre-diabetes 2026-01-07T13:30:24.000Z daily 0.75 https://www.medxy.ai/news/precision-hypertension-management 2026-01-07T13:25:47.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-blood-pressure-management 2026-01-07T13:30:31.000Z daily 0.75 https://www.medxy.ai/news/ja/precision-hypertension-management-2 2026-01-07T13:30:44.000Z daily 0.75 https://www.medxy.ai/news/zh/%25e7%25b2%25be%25e5%2587%2586%25e9%25ab%2598%25e8%25a1%2580%25e5%258e%258b%25e7%25ae%25a1%25e7%2590%2586-%25e5%25bf%2583%25e8%25a1%2580%25e7%25ae%25a1%25e8%258e%25b7%25e7%259b%258a 2026-01-07T15:54:23.000Z daily 0.75 https://www.medxy.ai/news/rethinking-anticoagulation-afib 2026-01-07T15:50:55.000Z daily 0.75 https://www.medxy.ai/news/vi/reassessing-anticoagulation-elderly 2026-01-07T15:54:30.000Z daily 0.75 https://www.medxy.ai/news/large-clonal-hematopoiesis-hiv-risk 2026-01-07T15:59:33.000Z daily 0.75 https://www.medxy.ai/news/ja/rethink-anticoagulation-therapy 2026-01-07T16:02:17.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-anticoagulation-in-elderly 2026-01-07T16:02:25.000Z daily 0.75 https://www.medxy.ai/news/vi/clonal-hematologic-subtypes-hiv-heart-risk 2026-01-07T16:01:05.000Z daily 0.75 https://www.medxy.ai/news/ja/hiv-heart-attack-risk 2026-01-07T16:02:43.000Z daily 0.75 https://www.medxy.ai/news/zh/large-clonal-hematopoiesis-hiv-heart-risk 2026-01-07T16:02:52.000Z daily 0.75 https://www.medxy.ai/news/beyond-child-survival 2026-01-07T16:06:14.000Z daily 0.75 https://www.medxy.ai/news/vi/children-health-burden 2026-01-07T19:21:26.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-infections-burden 2026-01-07T19:21:36.000Z daily 0.75 https://www.medxy.ai/news/zh/global-burden-respiratory-infections 2026-01-07T19:21:44.000Z daily 0.75 https://www.medxy.ai/news/oral-zoliflodacin-gonorrhoea 2026-01-07T16:14:42.000Z daily 0.75 https://www.medxy.ai/news/vi/zoliflodacin-vs-standard-therapy 2026-01-07T19:21:58.000Z daily 0.75 https://www.medxy.ai/news/ja/oral-zoliflodacin-equivalence 2026-01-07T19:22:06.000Z daily 0.75 https://www.medxy.ai/news/zh/oral-zoliflodacin-gonorrhea-treatment 2026-01-07T19:22:13.000Z daily 0.75 https://www.medxy.ai/news/rising-sarcoidosis-burden 2026-01-07T16:28:47.000Z daily 0.75 https://www.medxy.ai/news/vi/sarcoidosis-burden-uk 2026-01-07T19:22:24.000Z daily 0.75 https://www.medxy.ai/news/ja/sarcoidosis-burden-england 2026-01-07T19:22:43.000Z daily 0.75 https://www.medxy.ai/news/zh/burden-of-sarcoidosis 2026-01-07T19:22:53.000Z daily 0.75 https://www.medxy.ai/news/ceftriaxone-resistance-gonorrhoeae 2026-01-07T17:03:51.000Z daily 0.75 https://www.medxy.ai/news/vi/ceftriaxone-resistance-gonorrhoeae-2 2026-01-07T19:23:04.000Z daily 0.75 https://www.medxy.ai/news/ja/ceftriaxone-resistant-gonorrhea-2 2026-01-07T19:23:12.000Z daily 0.75 https://www.medxy.ai/news/zh/ceftriaxone-resistant-gonorrhea 2026-01-07T19:23:24.000Z daily 0.75 https://www.medxy.ai/news/breaking-chronic-wound-cycle 2026-01-07T19:21:09.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-chronic-wound-cycle-2 2026-01-07T19:52:17.000Z daily 0.75 https://www.medxy.ai/news/ja/breaking-chronic-injury-cycle 2026-01-07T19:52:28.000Z daily 0.75 https://www.medxy.ai/news/zh/breaking-chronic-wound-cycle-3 2026-01-07T19:52:38.000Z daily 0.75 https://www.medxy.ai/news/functional-cure-gsk-bepirovirsen 2026-01-07T19:27:43.000Z daily 0.75 https://www.medxy.ai/news/vi/cure-hepatitis-b 2026-01-07T19:52:46.000Z daily 0.75 https://www.medxy.ai/news/ja/hepatitis-c-trial-success 2026-01-07T19:52:59.000Z daily 0.75 https://www.medxy.ai/news/zh/functional-cure-gsk-trial 2026-01-07T19:53:33.000Z daily 0.75 https://www.medxy.ai/news/fda-drug-approvals-2025 2026-01-07T19:49:06.000Z daily 0.75 https://www.medxy.ai/news/vi/fda-drug-approvals-2025-2 2026-01-07T21:30:21.000Z daily 0.75 https://www.medxy.ai/news/ja/2025-fda-drug-approval-review 2026-01-07T21:40:47.000Z daily 0.75 https://www.medxy.ai/news/zh/2025-fda-drug-approvals 2026-01-07T21:40:29.000Z daily 0.75 https://www.medxy.ai/news/scheduled-early-birth-prevent-pre-eclampsia 2026-01-17T19:18:24.000Z daily 0.75 https://www.medxy.ai/news/vi/early-planning-prevention-gestational-hypertension 2026-01-08T09:56:15.000Z daily 0.75 https://www.medxy.ai/news/ja/scheduled-early-delivery 2026-01-08T09:56:22.000Z daily 0.75 https://www.medxy.ai/news/zh/early-delivery-strategies 2026-01-08T09:56:26.000Z daily 0.75 https://www.medxy.ai/news/industrial-food-preservatives-cancer-risk 2026-01-08T09:16:15.000Z daily 0.75 https://www.medxy.ai/news/vi/food-preservatives-cancer-risk 2026-01-08T09:56:36.000Z daily 0.75 https://www.medxy.ai/news/ja/food-additives-cancer-risk-2 2026-01-08T09:56:44.000Z daily 0.75 https://www.medxy.ai/news/zh/food-additives-cancer-risk 2026-01-08T09:56:57.000Z daily 0.75 https://www.medxy.ai/news/music-therapy-anxiety 2026-01-08T09:57:12.000Z daily 0.75 https://www.medxy.ai/news/vi/music-therapy-anxiety-results 2026-01-08T09:57:21.000Z daily 0.75 https://www.medxy.ai/news/ja/music-therapy-anxiety-management 2026-01-08T09:57:33.000Z daily 0.75 https://www.medxy.ai/news/zh/music-therapy-cancer-anxiety 2026-01-08T09:57:42.000Z daily 0.75 https://www.medxy.ai/news/elacestrant-esr1-breast-cancer-2 2026-01-08T09:57:53.000Z daily 0.75 https://www.medxy.ai/news/vi/elacestrant-esr1-breast-cancer 2026-01-08T09:58:04.000Z daily 0.75 https://www.medxy.ai/news/ja/elacestrant-esr1-mutant-breast-cancer 2026-01-08T14:11:59.000Z daily 0.75 https://www.medxy.ai/news/zh/elacestrant-esr1-breast-cancer-3 2026-01-08T14:12:05.000Z daily 0.75 https://www.medxy.ai/news/optimizing-tnbc-immunotherapy 2026-01-08T14:12:14.000Z daily 0.75 https://www.medxy.ai/news/vi/optimize-immunotherapy-breast-cancer 2026-01-08T14:12:19.000Z daily 0.75 https://www.medxy.ai/news/ja/triple-negative-breast-cancer-immunotherapy 2026-01-08T14:28:24.000Z daily 0.75 https://www.medxy.ai/news/zh/immunotherapy-triple-negative-breast-cancer 2026-01-08T14:28:14.000Z daily 0.75 https://www.medxy.ai/news/chemotherapy-free-future-h2020 2026-01-08T14:28:08.000Z daily 0.75 https://www.medxy.ai/news/ctdna-dynamics-treatment-success 2026-01-08T14:28:00.000Z daily 0.75 https://www.medxy.ai/news/vi/ctdna-predicts-breast-cancer 2026-01-08T14:30:54.000Z daily 0.75 https://www.medxy.ai/news/ja/ctdna-dynamics-predicts-treatment-success 2026-01-08T14:31:05.000Z daily 0.75 https://www.medxy.ai/news/not-more-is-better 2026-01-08T14:30:37.000Z daily 0.75 https://www.medxy.ai/news/zh/ctdna-prediction-breast-cancer 2026-01-08T14:59:39.000Z daily 0.75 https://www.medxy.ai/news/vi/not-more-is-better-2 2026-01-08T14:59:47.000Z daily 0.75 https://www.medxy.ai/news/zh/more-is-not-always-better 2026-01-08T14:59:58.000Z daily 0.75 https://www.medxy.ai/news/megestrol-letrozole-breast-cancer 2026-01-08T15:01:36.000Z daily 0.75 https://www.medxy.ai/news/vi/megestrol-letrozole-breast-cancer-2 2026-01-08T17:40:13.000Z daily 0.75 https://www.medxy.ai/news/ja/improving-er-breast-cancer 2026-01-08T17:40:17.000Z daily 0.75 https://www.medxy.ai/news/zh/dihydrotestosterone-and-breast-cancer 2026-01-08T17:40:22.000Z daily 0.75 https://www.medxy.ai/news/muscle-bone-ratio-biomarker 2026-01-08T18:05:37.000Z daily 0.75 https://www.medxy.ai/news/vi/cancer-treatment-ai-forecast 2026-01-08T18:12:23.000Z daily 0.75 https://www.medxy.ai/news/ai-sarcopenia-metrics-survival 2026-01-08T18:09:04.000Z daily 0.75 https://www.medxy.ai/news/ja/muscle-bone-ratio-biomarker-2 2026-01-08T18:12:40.000Z daily 0.75 https://www.medxy.ai/news/vi/sarcopenia-ai-predictions 2026-01-08T18:12:48.000Z daily 0.75 https://www.medxy.ai/news/zh/muscle-bone-ratio-ai-biomarker 2026-01-08T18:13:13.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-sarcopenia-indicator-ras-colon-cancer 2026-01-08T18:55:06.000Z daily 0.75 https://www.medxy.ai/news/zh/muscle-loss-predictors-egfr-treatment 2026-01-08T18:55:01.000Z daily 0.75 https://www.medxy.ai/news/multiantigen-t-cell-therapy-pancreatic-cancer 2026-01-08T18:16:02.000Z daily 0.75 https://www.medxy.ai/news/vi/targeted-t-cell-therapy-pancreatic-cancer 2026-01-08T18:55:26.000Z daily 0.75 https://www.medxy.ai/news/zh/multi-antigen-t-cell-therapy-pancreatic-cancer 2026-01-08T18:55:39.000Z daily 0.75 https://www.medxy.ai/news/high-ultra-processed-food-mortality 2026-01-08T18:55:53.000Z daily 0.75 https://www.medxy.ai/news/vi/processed-food-consumption 2026-01-08T18:56:05.000Z daily 0.75 https://www.medxy.ai/news/ja/high-processed-foods-black-women-cancer-mortality 2026-01-08T18:56:14.000Z daily 0.75 https://www.medxy.ai/news/zh/processed-foods-black-survivors 2026-01-08T18:56:26.000Z daily 0.75 https://www.medxy.ai/news/local-and-metastasis-therapies 2026-01-08T18:57:38.000Z daily 0.75 https://www.medxy.ai/news/vi/integration-of-seed-therapy-and-metastatic-treatment-in-oligometastatic-prostate-cancer 2026-01-08T19:02:58.000Z daily 0.75 https://www.medxy.ai/news/ja/localized-therapy-integration 2026-01-08T19:03:05.000Z daily 0.75 https://www.medxy.ai/news/zh/local-treatment-integration-prostate-cancer 2026-01-08T19:11:53.000Z daily 0.75 https://www.medxy.ai/news/dual-action-nano-platform 2026-01-08T19:03:40.000Z daily 0.75 https://www.medxy.ai/news/vi/nano-icym2-cancer-immunity 2026-01-08T19:12:05.000Z daily 0.75 https://www.medxy.ai/news/ja/icym2-nanoplatform-pcbc-immune-activation 2026-01-08T19:12:47.000Z daily 0.75 https://www.medxy.ai/news/trastuzumab-deruxtecan-nsclc 2026-01-08T19:14:24.000Z daily 0.75 https://www.medxy.ai/news/zh/double-effect-icym2-nano-platform 2026-01-08T19:13:03.000Z daily 0.75 https://www.medxy.ai/news/vi/trastuzumab-deruxtecan-nsclc-her2 2026-01-08T19:15:23.000Z daily 0.75 https://www.medxy.ai/news/ja/her2-nsclc-trastuzumab 2026-01-08T19:22:49.000Z daily 0.75 https://www.medxy.ai/news/zh/trastuzumab-deruxtecan-nsclc-2 2026-01-08T19:22:29.000Z daily 0.75 https://www.medxy.ai/news/hsp90-inhibition-xl888-analysis 2026-01-08T19:16:25.000Z daily 0.75 https://www.medxy.ai/news/vi/hsp90-inhibition-xl888-pd-1-cancer 2026-01-08T19:23:02.000Z daily 0.75 https://www.medxy.ai/news/ja/hsp90-inhibitor-failure 2026-01-08T19:23:16.000Z daily 0.75 https://www.medxy.ai/news/zh/xl888-hsp90-pancreatic-cancer 2026-01-08T19:23:22.000Z daily 0.75 https://www.medxy.ai/news/carboplatin-adjuvant-care 2026-01-08T19:21:33.000Z daily 0.75 https://www.medxy.ai/news/precision-rechallenge-liquid-biopsy 2026-01-08T19:24:38.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-challenge-cgp-liquid-biospy 2026-01-08T20:11:32.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-challenge-liquid-biopsy 2026-01-08T20:11:41.000Z daily 0.75 https://www.medxy.ai/news/low-dose-pembrolizumab-tnbc-2 2026-01-08T20:11:47.000Z daily 0.75 https://www.medxy.ai/news/vi/low-dose-pembrolizumab-tnbc 2026-01-08T20:11:54.000Z daily 0.75 https://www.medxy.ai/news/ja/planet-trial-insights-tnbc 2026-01-08T20:12:04.000Z daily 0.75 https://www.medxy.ai/news/zh/low-dose-pembrolizumab-triple-negative-breast-cancer 2026-01-08T20:12:09.000Z daily 0.75 https://www.medxy.ai/news/low-pass-wgbs-ctdna-monitoring 2026-01-08T23:21:10.000Z daily 0.75 https://www.medxy.ai/news/vi/bisulfite-genome-analysis-ctdna 2026-01-08T23:22:42.000Z daily 0.75 https://www.medxy.ai/news/ja/ctdna-monitoring-colorectal-cancer-2 2026-01-08T23:22:57.000Z daily 0.75 https://www.medxy.ai/news/zh/ctdna-monitoring-colorectal-cancer 2026-01-08T23:23:09.000Z daily 0.75 https://www.medxy.ai/news/axl-colorectal-cancer 2026-01-09T08:46:27.000Z daily 0.75 https://www.medxy.ai/news/precision-management-hr-advanced-breast-cancer 2026-01-09T09:48:21.000Z daily 0.75 https://www.medxy.ai/news/vi/cdk4-6i-therapy-breast-cancer 2026-01-09T09:48:28.000Z daily 0.75 https://www.medxy.ai/news/ja/cdk4-6i-precision-management 2026-01-09T09:48:35.000Z daily 0.75 https://www.medxy.ai/news/zh/precise-cdk4-6-inhibitor-management 2026-01-09T09:48:44.000Z daily 0.75 https://www.medxy.ai/news/national-expertise-cancer-survival 2026-01-09T09:48:02.000Z daily 0.75 https://www.medxy.ai/news/vi/national-expertise-cup-mtb 2026-01-09T15:53:27.000Z daily 0.75 https://www.medxy.ai/news/ja/unknown-cancer-survival-insights 2026-01-09T15:53:33.000Z daily 0.75 https://www.medxy.ai/news/zh/experts-on-cancer-survival 2026-01-09T15:53:40.000Z daily 0.75 https://www.medxy.ai/news/dual-blockade-capivasertib-abiraterone 2026-01-09T10:34:48.000Z daily 0.75 https://www.medxy.ai/news/vi/akt-ar-trial-capivasertib-abiraterone 2026-01-09T15:53:50.000Z daily 0.75 https://www.medxy.ai/news/ja/akt-ar-pathway-blockade-2 2026-01-09T15:53:57.000Z daily 0.75 https://www.medxy.ai/news/zh/akt-ar-pathway-blockade 2026-01-09T15:54:05.000Z daily 0.75 https://www.medxy.ai/news/improving-persistence-abemaciclib-tolerability 2026-01-09T15:54:13.000Z daily 0.75 https://www.medxy.ai/news/vi/improving-persistence-abemaciclib-breast-cancer 2026-01-09T15:54:22.000Z daily 0.75 https://www.medxy.ai/news/ja/sustainability-improvement-abemaciclib-tolerance 2026-01-09T15:54:28.000Z daily 0.75 https://www.medxy.ai/news/zh/improving-compliance-abemaciclib-tolerance 2026-01-09T15:54:39.000Z daily 0.75 https://www.medxy.ai/news/alectinib-alk-positive-nsclc 2026-01-09T11:38:15.000Z daily 0.75 https://www.medxy.ai/news/vi/alectinib-alc-trial-results 2026-01-09T15:54:53.000Z daily 0.75 https://www.medxy.ai/news/ja/alectinib-alk-nsclc-survival 2026-01-09T15:55:06.000Z daily 0.75 https://www.medxy.ai/news/zh/alectinib-alk-positive-nsclc-2 2026-01-09T15:55:13.000Z daily 0.75 https://www.medxy.ai/news/new-era-datopotamab 2026-01-09T15:55:19.000Z daily 0.75 https://www.medxy.ai/news/datopotamab-deruxtecan-breast-cancer-2 2026-01-09T15:55:25.000Z daily 0.75 https://www.medxy.ai/news/vi/datopotamab-deruxtecan-breast-cancer-3 2026-01-09T15:55:31.000Z daily 0.75 https://www.medxy.ai/news/ja/datopotamab-deruxtecan-hormonal-cancer 2026-01-09T15:55:37.000Z daily 0.75 https://www.medxy.ai/news/zh/datopotamab-deruxtecan-breast-cancer 2026-01-09T15:55:42.000Z daily 0.75 https://www.medxy.ai/news/vi/atezolizumab-bcg-nmibc 2026-01-09T15:55:53.000Z daily 0.75 https://www.medxy.ai/news/ja/high-risk-nmibc-atizolizumab-bcg 2026-01-09T15:55:57.000Z daily 0.75 https://www.medxy.ai/news/zh/atezolizumab-bcg-bladder-cancer 2026-01-09T15:56:07.000Z daily 0.75 https://www.medxy.ai/news/overcoming-resistance-apg-2449 2026-01-09T15:35:34.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-drug-resistance-nsclc 2026-01-09T15:56:32.000Z daily 0.75 https://www.medxy.ai/news/ja/overcoming-resistance-nsclc 2026-01-09T15:56:49.000Z daily 0.75 https://www.medxy.ai/news/zh/overcoming-alk-positive-nsclc-resistance 2026-01-09T15:59:35.000Z daily 0.75 https://www.medxy.ai/news/stockholm3-vs-psa-prostate-cancer 2026-01-09T16:00:35.000Z daily 0.75 https://www.medxy.ai/news/vi/stockholm3-vs-psa-prostate-cancer-2 2026-01-09T16:07:22.000Z daily 0.75 https://www.medxy.ai/news/ja/stockholm-3-psa-prostate-screening 2026-01-09T16:07:39.000Z daily 0.75 https://www.medxy.ai/news/zh/stockholm3-psa-prostate-cancer-comparison 2026-01-09T16:07:46.000Z daily 0.75 https://www.medxy.ai/news/bone-metabolism-biomarkers 2026-01-09T16:13:33.000Z daily 0.75 https://www.medxy.ai/news/vi/bone-metabolism-biomarker 2026-01-09T16:13:52.000Z daily 0.75 https://www.medxy.ai/news/ja/bone-metabolism-biomarkers-2 2026-01-10T14:25:39.000Z daily 0.75 https://www.medxy.ai/news/nano-knife-revolution 2026-01-10T14:20:15.000Z daily 0.75 https://www.medxy.ai/news/audit-feedback-nmibc-surgery 2026-01-10T14:22:05.000Z daily 0.75 https://www.medxy.ai/news/vi/audit-feedback-nmibc-surgery-2 2026-01-10T14:25:48.000Z daily 0.75 https://www.medxy.ai/news/ja/bladder-cancer-audit 2026-01-10T14:30:32.000Z daily 0.75 https://www.medxy.ai/news/zh/nmibc-audit-feedback 2026-01-10T14:30:23.000Z daily 0.75 https://www.medxy.ai/news/c-peptide-barrier-insulin-delivery 2026-01-10T14:27:59.000Z daily 0.75 https://www.medxy.ai/news/tirzepatide-mash-treatment 2026-01-10T14:31:33.000Z daily 0.75 https://www.medxy.ai/news/vi/tirzepatide-mash-future 2026-01-10T14:32:07.000Z daily 0.75 https://www.medxy.ai/news/ja/tirzepatide-mash-future-2 2026-01-10T14:34:41.000Z daily 0.75 https://www.medxy.ai/news/multimodal-ai-vs-nomograms 2026-01-10T14:48:14.000Z daily 0.75 https://www.medxy.ai/news/vi/superior-multimodal-ai-prediction 2026-01-10T14:47:45.000Z daily 0.75 https://www.medxy.ai/news/ja/multi-modal-ai-improves-prediction 2026-01-10T14:47:57.000Z daily 0.75 https://www.medxy.ai/news/zh/multimodal-ai-better-than-clinical-graphs 2026-01-10T14:48:06.000Z daily 0.75 https://www.medxy.ai/news/modulating-starch-digestibility 2026-01-10T14:47:38.000Z daily 0.75 https://www.medxy.ai/news/vi/adjusting-starch-digestion 2026-01-10T14:52:17.000Z daily 0.75 https://www.medxy.ai/news/ja/controlling-starch-digestion 2026-01-10T16:41:28.000Z daily 0.75 https://www.medxy.ai/news/zh/starch-digestion-regulation 2026-01-10T16:41:35.000Z daily 0.75 https://www.medxy.ai/news/molecular-imaging-pet-guided-therapy 2026-01-10T15:02:48.000Z daily 0.75 https://www.medxy.ai/news/vi/molecular-imaging-pet-radiotherapy 2026-01-10T16:41:45.000Z daily 0.75 https://www.medxy.ai/news/ja/molecular-imaging-pet-enhancement 2026-01-10T16:41:55.000Z daily 0.75 https://www.medxy.ai/news/zh/molecular-imaging-pet-radiotherapy-insights 2026-01-10T16:42:06.000Z daily 0.75 https://www.medxy.ai/news/donor-diabetes-status-dmek-outcomes 2026-01-10T16:52:31.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-status-donor-dmek 2026-01-10T16:52:36.000Z daily 0.75 https://www.medxy.ai/news/ja/donor-diabetes-status-dmek-results 2026-01-10T16:51:59.000Z daily 0.75 https://www.medxy.ai/news/zh/donor-diabetes-dmek-effect 2026-01-10T16:52:08.000Z daily 0.75 https://www.medxy.ai/news/optimizing-mash-management 2026-01-10T16:53:20.000Z daily 0.75 https://www.medxy.ai/news/vi/mash-management-optimization-2 2026-01-10T17:40:25.000Z daily 0.75 https://www.medxy.ai/news/ja/mash-management-optimization 2026-01-10T17:40:30.000Z daily 0.75 https://www.medxy.ai/news/zh/optimize-mash-management 2026-01-10T17:40:36.000Z daily 0.75 https://www.medxy.ai/news/noncontrast-mri-screening 2026-01-10T17:40:12.000Z daily 0.75 https://www.medxy.ai/news/vi/mri-screening-strategy-prostate-cancer 2026-01-10T18:52:15.000Z daily 0.75 https://www.medxy.ai/news/ja/paradigm-shift-mri-screening-prostate-cancer 2026-01-10T18:52:22.000Z daily 0.75 https://www.medxy.ai/news/zh/paradigm-shift-prostate-cancer-detection 2026-01-10T18:52:33.000Z daily 0.75 https://www.medxy.ai/news/finerenone-diabetes-kidney 2026-01-10T17:45:11.000Z daily 0.75 https://www.medxy.ai/news/finerenone-albuminuria-five-star 2026-01-10T17:51:11.000Z daily 0.75 https://www.medxy.ai/news/vi/finerenone-protein-reduction 2026-01-10T18:52:47.000Z daily 0.75 https://www.medxy.ai/news/ja/finenolon-albuminuria-reduction 2026-01-10T18:52:55.000Z daily 0.75 https://www.medxy.ai/news/zh/fenofibrate-reduces-proteinuria 2026-01-10T18:53:03.000Z daily 0.75 https://www.medxy.ai/news/evolving-nmibc-therapy 2026-01-10T18:50:37.000Z daily 0.75 https://www.medxy.ai/news/vi/high-risk-nmibc-combination-therapy 2026-01-10T18:56:15.000Z daily 0.75 https://www.medxy.ai/news/ja/high-risk-nmibc-paradigm 2026-01-10T18:55:58.000Z daily 0.75 https://www.medxy.ai/news/zh/evolution-of-nmibc-treatment 2026-01-10T18:57:12.000Z daily 0.75 https://www.medxy.ai/news/pet-ct-immunotherapy-discontinuation 2026-01-10T18:57:54.000Z daily 0.75 https://www.medxy.ai/news/vi/stop-immunotherapy-pet-ct-lung-cancer 2026-01-10T20:34:59.000Z daily 0.75 https://www.medxy.ai/news/ja/pet-ct-immunotherapy-discontinuation-2 2026-01-10T20:35:18.000Z daily 0.75 https://www.medxy.ai/news/zh/pet-ct-immune-therapy-stop 2026-01-10T20:35:26.000Z daily 0.75 https://www.medxy.ai/news/vi/video-consultations-insulin-pump 2026-01-10T19:02:48.000Z daily 0.75 https://www.medxy.ai/news/vi/video-consultation-diabetes-type1 2026-01-10T20:35:33.000Z daily 0.75 https://www.medxy.ai/news/ja/insulin-pump-treatment 2026-01-10T20:35:39.000Z daily 0.75 https://www.medxy.ai/news/zh/video-consultation-insulin-pump 2026-01-10T20:35:45.000Z daily 0.75 https://www.medxy.ai/news/mobile-health-management-gd-reduction 2026-01-11T09:00:47.000Z daily 0.75 https://www.medxy.ai/news/vi/mobile-health-model-reducing-diabetes 2026-01-11T09:00:33.000Z daily 0.75 https://www.medxy.ai/news/ja/mobile-health-model-reduces-gestational-diabetes 2026-01-11T09:00:25.000Z daily 0.75 https://www.medxy.ai/news/zh/mobile-health-model-reduces-gdm 2026-01-11T09:00:14.000Z daily 0.75 https://www.medxy.ai/news/moderate-diets-prediabetes 2026-01-10T20:46:36.000Z daily 0.75 https://www.medxy.ai/news/probiotics-periodontitis-diabetes 2026-01-11T09:00:02.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-oral-cavity-probiotic-benefits 2026-01-11T08:59:57.000Z daily 0.75 https://www.medxy.ai/news/zh/probiotics-periodontitis-diabetes-2 2026-01-11T08:59:46.000Z daily 0.75 https://www.medxy.ai/news/nordic-diet-vs-high-fat 2026-01-11T08:49:46.000Z daily 0.75 https://www.medxy.ai/news/vi/nordic-diet-vs-high-fat-2 2026-01-11T08:59:15.000Z daily 0.75 https://www.medxy.ai/news/zh/healthy-nordic-diet-results 2026-01-11T08:59:04.000Z daily 0.75 https://www.medxy.ai/news/double-win-diet 2026-01-11T08:59:21.000Z daily 0.75 https://www.medxy.ai/news/planetary-health-diet-masld-risk 2026-01-11T09:01:37.000Z daily 0.75 https://www.medxy.ai/news/vi/planetary-health-diet-cesm-reduction 2026-01-11T16:37:23.000Z daily 0.75 https://www.medxy.ai/news/ja/planetary-diet-compliance-masld-risk 2026-01-11T16:37:34.000Z daily 0.75 https://www.medxy.ai/news/zh/planetary-health-diet-2 2026-01-11T16:37:44.000Z daily 0.75 https://www.medxy.ai/news/nurturing-children-planet 2026-01-11T16:23:21.000Z daily 0.75 https://www.medxy.ai/news/planetary-health-diet 2026-01-11T16:27:34.000Z daily 0.75 https://www.medxy.ai/news/planetary-health-diet-kidney-benefits 2026-01-11T16:36:50.000Z daily 0.75 https://www.medxy.ai/news/vi/diet-for-planet-health-2 2026-01-11T18:37:30.000Z daily 0.75 https://www.medxy.ai/news/ja/planetary-diet-chronic-kidney-disease-2 2026-01-11T18:37:44.000Z daily 0.75 https://www.medxy.ai/news/planetary-health-diet-kidneys 2026-01-11T16:43:27.000Z daily 0.75 https://www.medxy.ai/news/zh/planetary-diet-chronic-kidney-disease 2026-01-11T18:38:00.000Z daily 0.75 https://www.medxy.ai/news/planetary-health-diet-3 2026-01-11T18:38:11.000Z daily 0.75 https://www.medxy.ai/news/vi/healthy-planet-diet 2026-01-11T18:38:23.000Z daily 0.75 https://www.medxy.ai/news/ja/planetary-health-diet-4 2026-01-11T18:38:33.000Z daily 0.75 https://www.medxy.ai/news/zh/planetary-health-diet-5 2026-01-11T18:38:38.000Z daily 0.75 https://www.medxy.ai/news/dietary-phytomix-t2d-management 2026-01-11T16:49:43.000Z daily 0.75 https://www.medxy.ai/news/vi/phytomix-t2d-management 2026-01-11T18:38:46.000Z daily 0.75 https://www.medxy.ai/news/ja/dibifree-t2d-management 2026-01-11T18:38:53.000Z daily 0.75 https://www.medxy.ai/news/zh/dibifree-diabetes-management 2026-01-11T18:39:00.000Z daily 0.75 https://www.medxy.ai/news/resveratrol-type-2-diabetes 2026-01-11T16:58:13.000Z daily 0.75 https://www.medxy.ai/news/immune-reservoir-cancer 2026-01-11T16:59:53.000Z daily 0.75 https://www.medxy.ai/news/vi/immune-reserve-conservation 2026-01-11T18:39:15.000Z daily 0.75 https://www.medxy.ai/news/ja/immune-reservoir-preservation 2026-01-11T18:39:24.000Z daily 0.75 https://www.medxy.ai/news/zh/immune-reserve-protection 2026-01-11T18:39:35.000Z daily 0.75 https://www.medxy.ai/news/eribulin-clinical-efficacy-2 2026-01-11T18:39:40.000Z daily 0.75 https://www.medxy.ai/news/vi/eribulin-angiosarcoma-hemangioendothelioma 2026-01-11T18:39:45.000Z daily 0.75 https://www.medxy.ai/news/ja/eribulin-efficacy-metastatic-sarcoma 2026-01-11T18:39:51.000Z daily 0.75 https://www.medxy.ai/news/zh/eribulin-clinical-efficacy 2026-01-11T18:39:56.000Z daily 0.75 https://www.medxy.ai/news/mapk-mutations-ivosidenib-resistance 2026-01-11T17:16:46.000Z daily 0.75 https://www.medxy.ai/news/vi/mapk-mutations-ivosidenib-resistance-2 2026-01-11T18:40:04.000Z daily 0.75 https://www.medxy.ai/news/ja/mapk-pathway-mutations-idh1-resistance 2026-01-11T18:40:15.000Z daily 0.75 https://www.medxy.ai/news/zh/mapk-mutations-idh1-cholangiocarcinoma-resistance 2026-01-11T18:40:20.000Z daily 0.75 https://www.medxy.ai/news/erdafitinib-response-fgfr-cholangiocarcinoma 2026-01-11T17:24:31.000Z daily 0.75 https://www.medxy.ai/news/vi/erdafitinib-55-percent-response-cholangiocarcinoma 2026-01-11T18:40:28.000Z daily 0.75 https://www.medxy.ai/news/ja/erdafitinib-fgfr-mutations-bile-duct-cancer 2026-01-11T18:40:32.000Z daily 0.75 https://www.medxy.ai/news/zh/erdafitinib-fgfr-biliary-cancer 2026-01-11T18:40:36.000Z daily 0.75 https://www.medxy.ai/news/genomic-evolution-breast-cancer 2026-01-11T18:40:41.000Z daily 0.75 https://www.medxy.ai/news/vi/breast-cancer-genetics 2026-01-11T18:40:47.000Z daily 0.75 https://www.medxy.ai/news/ja/breast-cancer-genome-evolution-2 2026-01-11T18:40:52.000Z daily 0.75 https://www.medxy.ai/news/zh/breast-cancer-genome-evolution 2026-01-11T18:41:00.000Z daily 0.75 https://www.medxy.ai/news/induce-3-trial-failure 2026-01-11T18:41:51.000Z daily 0.75 https://www.medxy.ai/news/vi/induces-3-trial-feladilimab-pembrolizumab 2026-01-11T20:23:31.000Z daily 0.75 https://www.medxy.ai/news/ja/induce-3-trial-results-2 2026-01-11T20:23:37.000Z daily 0.75 https://www.medxy.ai/news/zh/induce-3-trial-results 2026-01-11T20:23:44.000Z daily 0.75 https://www.medxy.ai/news/precision-management-kras-g12v-nsclc 2026-01-11T18:52:56.000Z daily 0.75 https://www.medxy.ai/news/zh/kras-g12v-nsclc-management-2 2026-01-11T20:23:55.000Z daily 0.75 https://www.medxy.ai/news/vi/kras-g12v-nsclc-management-3 2026-01-11T20:24:02.000Z daily 0.75 https://www.medxy.ai/news/ja/kras-g12v-nsclc-management 2026-01-11T20:24:09.000Z daily 0.75 https://www.medxy.ai/news/olaparib-pembrolizumab-strategy 2026-01-11T20:25:35.000Z daily 0.75 https://www.medxy.ai/news/vi/keylynk-009-olaparib-pembrolizumab 2026-01-11T20:25:39.000Z daily 0.75 https://www.medxy.ai/news/ja/keylynk-009-combination-therapy 2026-01-11T20:25:44.000Z daily 0.75 https://www.medxy.ai/news/zh/olaparib-pembrolizumab-tnbc-treatment 2026-01-11T20:25:48.000Z daily 0.75 https://www.medxy.ai/news/neoadjuvant-nivolumab-head-neck-cancer 2026-01-11T20:25:56.000Z daily 0.75 https://www.medxy.ai/news/vi/nivolumab-neoadjuvant-cancer-response 2026-01-11T20:26:07.000Z daily 0.75 https://www.medxy.ai/news/zh/neo-adjuvant-nivolumab-chemo-hnscc 2026-01-11T20:27:39.000Z daily 0.75 https://www.medxy.ai/news/denosumab-recurrent-osteosarcoma-trial 2026-01-11T20:27:27.000Z daily 0.75 https://www.medxy.ai/news/vi/denosumab-osteosarcoma-results-2 2026-01-11T20:56:54.000Z daily 0.75 https://www.medxy.ai/news/ja/denosumab-osteosarcoma-results 2026-01-11T20:57:03.000Z daily 0.75 https://www.medxy.ai/news/zh/dino-mab-in-recurrent-osteosarcoma 2026-01-11T20:57:09.000Z daily 0.75 https://www.medxy.ai/news/neoadjuvant-abemaciclib-therapy 2026-01-11T20:57:14.000Z daily 0.75 https://www.medxy.ai/news/vi/abemaciclib-letrozole-strategy 2026-01-11T20:57:21.000Z daily 0.75 https://www.medxy.ai/news/zh/abemaciclib-letrozole-breast-cancer 2026-01-11T20:57:33.000Z daily 0.75 https://www.medxy.ai/news/fdg-pet-dose-de-escalation 2026-01-11T20:57:47.000Z daily 0.75 https://www.medxy.ai/news/vi/fdg-pet-dose-reduction-2 2026-01-11T21:44:18.000Z daily 0.75 https://www.medxy.ai/news/ja/fdg-pet-dose-reduction-hpv-throat-cancer 2026-01-11T21:44:25.000Z daily 0.75 https://www.medxy.ai/news/zh/fdg-pet-dose-reduction 2026-01-11T21:44:30.000Z daily 0.75 https://www.medxy.ai/news/ahr-inhibition-ik-175 2026-01-11T21:40:40.000Z daily 0.75 https://www.medxy.ai/news/vi/ahr-inhibition-ik-175-2 2026-01-12T10:57:31.000Z daily 0.75 https://www.medxy.ai/news/ja/ik-175-ahr-inhibition 2026-01-12T10:57:23.000Z daily 0.75 https://www.medxy.ai/news/zh/ik-175-ahr-inhibitor 2026-01-11T23:41:16.000Z daily 0.75 https://www.medxy.ai/news/beyond-pd1-lbl-007 2026-01-11T21:49:46.000Z daily 0.75 https://www.medxy.ai/news/biomarker-precision-ovarian-cancer 2026-01-12T10:57:12.000Z daily 0.75 https://www.medxy.ai/news/msi-tmb-independent-predictors 2026-01-12T16:22:35.000Z daily 0.75 https://www.medxy.ai/news/vi/msi-tmb-independent-biomarkers 2026-01-12T16:25:09.000Z daily 0.75 https://www.medxy.ai/news/ja/msi-tmb-independent-biomarkers-2 2026-01-12T18:05:30.000Z daily 0.75 https://www.medxy.ai/news/zh/msi-h-tmb-h-predictors 2026-01-12T18:05:36.000Z daily 0.75 https://www.medxy.ai/news/antiviral-prophylaxis-ici-hbv-hcc 2026-01-12T18:00:07.000Z daily 0.75 https://www.medxy.ai/news/vi/preventing-viral-resistance 2026-01-12T18:05:44.000Z daily 0.75 https://www.medxy.ai/news/ja/antiviral-prevention-ici-use 2026-01-12T18:05:56.000Z daily 0.75 https://www.medxy.ai/news/zh/fair-competition-viral-prevention 2026-01-12T18:06:07.000Z daily 0.75 https://www.medxy.ai/news/fet-rearranged-myoepithelial-tumors 2026-01-12T18:11:51.000Z daily 0.75 https://www.medxy.ai/news/vi/fet-rearranged-sarcoma 2026-01-12T18:12:02.000Z daily 0.75 https://www.medxy.ai/news/ja/fet-reconfigured-mesothelioma 2026-01-12T18:12:53.000Z daily 0.75 https://www.medxy.ai/news/zh/fet-rearranged-sarcoma-2 2026-01-12T20:40:11.000Z daily 0.75 https://www.medxy.ai/news/biomarkers-immunotherapy-success 2026-01-12T18:48:29.000Z daily 0.75 https://www.medxy.ai/news/vi/biomarkers-in-prostate-cancer-2 2026-01-12T20:40:19.000Z daily 0.75 https://www.medxy.ai/news/ja/biomarkers-in-prostate-cancer 2026-01-12T20:40:27.000Z daily 0.75 https://www.medxy.ai/news/zh/benefit-biomarkers-tomb-msi 2026-01-12T20:40:37.000Z daily 0.75 https://www.medxy.ai/news/palbociclib-trastuzumab-endocrine-therapy 2026-01-12T20:40:46.000Z daily 0.75 https://www.medxy.ai/news/vi/palbociclib-trastuzumab-breast-cancer 2026-01-12T21:23:12.000Z daily 0.75 https://www.medxy.ai/news/ja/palbociclib-trastuzumab-endocrine-therapy-2 2026-01-12T21:23:17.000Z daily 0.75 https://www.medxy.ai/news/zh/pabosilib-her2-breast-cancer 2026-01-12T21:23:22.000Z daily 0.75 https://www.medxy.ai/news/synergistic-potential-sapacitabine-olaparib 2026-01-12T21:33:55.000Z daily 0.75 https://www.medxy.ai/news/vi/collaborative-potential-hematology 2026-01-12T21:34:00.000Z daily 0.75 https://www.medxy.ai/news/ja/synergy-and-challenges-in-brca-mutant-breast-cancer 2026-01-12T21:34:05.000Z daily 0.75 https://www.medxy.ai/news/zh/collaboration-potential-hematologic-disorders 2026-01-12T21:34:10.000Z daily 0.75 https://www.medxy.ai/news/zanidatamab-therapy-her2-gastric-cancer 2026-01-12T21:33:02.000Z daily 0.75 https://www.medxy.ai/news/vi/zanidatamab-therapy-her2-cancer 2026-01-13T09:09:25.000Z daily 0.75 https://www.medxy.ai/news/ja/zanidatamab-therapy-her2-gastric-cancer-2 2026-01-13T09:09:33.000Z daily 0.75 https://www.medxy.ai/news/zh/zanidatamab-therapy-her2-gastric-cancer-3 2026-01-13T09:09:40.000Z daily 0.75 https://www.medxy.ai/news/ipatasertib-breast-cancer 2026-01-13T09:09:46.000Z daily 0.75 https://www.medxy.ai/news/vi/pi3k-akt-target-ipatasertib 2026-01-13T09:40:13.000Z daily 0.75 https://www.medxy.ai/news/ja/pi3k-akt-pathway-ipatasertib 2026-01-13T09:40:18.000Z daily 0.75 https://www.medxy.ai/news/zh/pi3k-akt-ipatasertib-breast-cancer 2026-01-13T09:40:24.000Z daily 0.75 https://www.medxy.ai/news/her2dx-testing-vs-histopathology 2026-01-13T09:36:55.000Z daily 0.75 https://www.medxy.ai/news/vi/her2dx-gen-testing 2026-01-13T09:40:35.000Z daily 0.75 https://www.medxy.ai/news/ja/her2dx-gene-test-advantage 2026-01-13T10:34:32.000Z daily 0.75 https://www.medxy.ai/news/zh/her2dx-testing-advantage 2026-01-13T10:34:41.000Z daily 0.75 https://www.medxy.ai/news/thag-regimen-pancreatic-cancer 2026-01-13T10:23:31.000Z daily 0.75 https://www.medxy.ai/news/vi/thag-protocol-pancreatic-cancer 2026-01-13T10:34:49.000Z daily 0.75 https://www.medxy.ai/news/ja/thag-therapy-pancreatic-cancer 2026-01-13T10:35:02.000Z daily 0.75 https://www.medxy.ai/news/zh/thag-pancreatic-cancer-results 2026-01-13T10:35:24.000Z daily 0.75 https://www.medxy.ai/news/automated-radiomics-serum-biomarkers 2026-01-13T10:30:53.000Z daily 0.75 https://www.medxy.ai/news/vi/automated-image-analysis-prostate-cancer 2026-01-13T10:35:35.000Z daily 0.75 https://www.medxy.ai/news/ja/automated-radio-mix-serum-biomarkers 2026-01-13T10:35:53.000Z daily 0.75 https://www.medxy.ai/news/zh/automated-imaging-biomarkers-prostate-cancer 2026-01-13T10:36:31.000Z daily 0.75 https://www.medxy.ai/news/prostate-cancer-breakthroughs 2026-01-13T10:36:47.000Z daily 0.75 https://www.medxy.ai/news/cabozantinib-nivolumab-efficacy 2026-01-13T10:53:55.000Z daily 0.75 https://www.medxy.ai/news/vi/cabozantinib-nivolumab-efficacy-2 2026-01-13T10:58:23.000Z daily 0.75 https://www.medxy.ai/news/ja/cobimetinib-nivolumab-combo-ineffective 2026-01-13T10:58:35.000Z daily 0.75 https://www.medxy.ai/news/zh/cabozantinib-nivolumab-limited-efficacy 2026-01-13T10:59:25.000Z daily 0.75 https://www.medxy.ai/news/immune-activation-lessons 2026-01-13T11:12:31.000Z daily 0.75 https://www.medxy.ai/news/vi/strong-immune-activation 2026-01-13T11:12:36.000Z daily 0.75 https://www.medxy.ai/news/ja/strong-immunity-activation-less-response 2026-01-13T11:12:43.000Z daily 0.75 https://www.medxy.ai/news/zh/strong-immunity-activation-failed 2026-01-13T11:12:51.000Z daily 0.75 https://www.medxy.ai/news/atezolizumab-tmb-high-efficacy 2026-01-13T11:12:57.000Z daily 0.75 https://www.medxy.ai/news/vi/atezolizumab-tmb-high-trial-results 2026-01-13T11:13:16.000Z daily 0.75 https://www.medxy.ai/news/ja/atezolizumab-tmb-high-effect 2026-01-13T11:14:48.000Z daily 0.75 https://www.medxy.ai/news/zh/artesunate-efficacy-tumors 2026-01-13T11:38:48.000Z daily 0.75 https://www.medxy.ai/news/sarco31-trial-mek-mtor-failure-2 2026-01-13T11:38:53.000Z daily 0.75 https://www.medxy.ai/news/vi/sarc031-experiment-mek-mtor 2026-01-13T11:38:59.000Z daily 0.75 https://www.medxy.ai/news/ja/sar031-study-failure 2026-01-13T11:39:05.000Z daily 0.75 https://www.medxy.ai/news/zh/sarco31-trial-mek-mtor-failure 2026-01-13T11:39:10.000Z daily 0.75 https://www.medxy.ai/news/esr1-mutations-endometrial-cancer 2026-01-13T11:30:27.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-breast-cancer-esr1-mutant 2026-01-13T11:39:18.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-breast-cancer-esr1-mutation 2026-01-13T11:39:26.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-breast-cancer 2026-01-13T11:39:35.000Z daily 0.75 https://www.medxy.ai/news/pegylated-liposomal-doxorubicin-desmoid-tumors-2 2026-01-13T11:39:40.000Z daily 0.75 https://www.medxy.ai/news/vi/pegylated-liposomal-doxorubicin 2026-01-13T11:39:45.000Z daily 0.75 https://www.medxy.ai/news/ja/pegylated-liposomal-doxorubicin-desmoid-tumors 2026-01-13T11:39:55.000Z daily 0.75 https://www.medxy.ai/news/zh/peg-liposomal-doxorubicin-trial 2026-01-13T12:10:46.000Z daily 0.75 https://www.medxy.ai/news/t-dxd-therapy-her2-low 2026-01-13T12:10:51.000Z daily 0.75 https://www.medxy.ai/news/vi/tdxd-combinations-breast-cancer 2026-01-13T12:10:56.000Z daily 0.75 https://www.medxy.ai/news/ja/t-dxd-her2-breast-cancer-2 2026-01-13T12:11:03.000Z daily 0.75 https://www.medxy.ai/news/zh/t-dxd-her2-breast-cancer 2026-01-13T12:11:08.000Z daily 0.75 https://www.medxy.ai/news/head-neck-cancer-immunotherapy 2026-01-13T11:50:32.000Z daily 0.75 https://www.medxy.ai/news/her2-positivity-biliary-cancer 2026-01-13T11:53:54.000Z daily 0.75 https://www.medxy.ai/news/vi/her2-positive-bile-duct-cancer-2 2026-01-13T12:11:19.000Z daily 0.75 https://www.medxy.ai/news/zh/her2-positive-bile-duct-cancer 2026-01-13T12:11:39.000Z daily 0.75 https://www.medxy.ai/news/dual-inhibition-vegf-egfr 2026-01-13T12:11:46.000Z daily 0.75 https://www.medxy.ai/news/vi/vegf-egfr-models 2026-01-13T12:11:55.000Z daily 0.75 https://www.medxy.ai/news/ja/vegf-egfr-dual-inhibition-2 2026-01-13T12:12:03.000Z daily 0.75 https://www.medxy.ai/news/zh/vegf-egfr-dual-inhibition 2026-01-13T12:12:08.000Z daily 0.75 https://www.medxy.ai/news/pd-l1-inhibition-car-t-dlbcl 2026-01-13T12:12:15.000Z daily 0.75 https://www.medxy.ai/news/vi/pd-l1-inhibition-car-t-therapy 2026-01-13T12:12:20.000Z daily 0.75 https://www.medxy.ai/news/ja/pd-l1-car-t-therapy 2026-01-13T12:12:25.000Z daily 0.75 https://www.medxy.ai/news/zh/pd-l1-car-t-enhancement 2026-01-13T12:12:32.000Z daily 0.75 https://www.medxy.ai/news/clinical-evolution-axicabtagene-ciloleucel 2026-01-13T12:12:45.000Z daily 0.75 https://www.medxy.ai/news/vi/axicabtagene-ciloleucel-clinical-advances 2026-01-13T12:12:50.000Z daily 0.75 https://www.medxy.ai/news/ja/aki-sabata-gen-clinical-evolution 2026-01-13T12:13:04.000Z daily 0.75 https://www.medxy.ai/news/zh/aki-sibatagirls-cell-evolution 2026-01-13T12:19:11.000Z daily 0.75 https://www.medxy.ai/news/machine-learning-predicts-breast-cancer 2026-01-13T13:22:57.000Z daily 0.75 https://www.medxy.ai/news/vi/machine-learning-breast-cancer 2026-01-13T13:23:02.000Z daily 0.75 https://www.medxy.ai/news/ja/ml-predicts-hr-her2-breast-cancer 2026-01-13T13:23:08.000Z daily 0.75 https://www.medxy.ai/news/zh/machine-learning-breast-cancer-recurrence 2026-01-13T13:23:14.000Z daily 0.75 https://www.medxy.ai/news/ianalumab-ibrutinib-therapy-discontinuation 2026-01-13T13:23:20.000Z daily 0.75 https://www.medxy.ai/news/vi/ibrutinib-ianalumab-remission 2026-01-13T13:23:32.000Z daily 0.75 https://www.medxy.ai/news/ja/ibrutinib-addition-cll-remission 2026-01-13T13:23:49.000Z daily 0.75 https://www.medxy.ai/news/zh/ibrutinib-cclc-deep-remission 2026-01-13T12:35:02.000Z daily 0.75 https://www.medxy.ai/news/emodepside-ivermectin-challenge 2026-01-13T12:34:57.000Z daily 0.75 https://www.medxy.ai/news/vi/emodepside-challenges-ivermectin 2026-01-13T13:24:03.000Z daily 0.75 https://www.medxy.ai/news/ja/emodeson-ivermectin-challenge 2026-01-13T13:24:12.000Z daily 0.75 https://www.medxy.ai/news/zh/emodiptil-challenges-ivermectin 2026-01-13T13:25:02.000Z daily 0.75 https://www.medxy.ai/news/postoperative-lymph-ctdna-recurrence 2026-01-13T13:25:50.000Z daily 0.75 https://www.medxy.ai/news/vi/lymphatic-fluid-cancer-recurrence 2026-01-13T13:25:43.000Z daily 0.75 https://www.medxy.ai/news/ja/surgical-ctdna-predicts-recurrence 2026-01-13T13:25:36.000Z daily 0.75 https://www.medxy.ai/news/zh/post-op-ctdna-hpv-negative-cancer 2026-01-13T13:25:31.000Z daily 0.75 https://www.medxy.ai/news/sutezolid-bactericidal-activity 2026-01-13T13:01:52.000Z daily 0.75 https://www.medxy.ai/news/vi/sutezolid-antimicrobial-effect 2026-01-13T13:26:00.000Z daily 0.75 https://www.medxy.ai/news/ja/stezolid-antibacterial-activity 2026-01-13T13:26:15.000Z daily 0.75 https://www.medxy.ai/news/zh/sutazolam-antimicrobial-activity 2026-01-13T13:26:20.000Z daily 0.75 https://www.medxy.ai/news/delpazolid-tb-trial-results 2026-01-13T13:07:30.000Z daily 0.75 https://www.medxy.ai/news/vi/delpazolid-lua-chon-an-toan 2026-01-13T13:26:29.000Z daily 0.75 https://www.medxy.ai/news/ja/delpazolid-tuberculosis-alternative 2026-01-13T13:26:40.000Z daily 0.75 https://www.medxy.ai/news/zh/delpazolid-safety-azole-antituberculosis 2026-01-13T13:26:49.000Z daily 0.75 https://www.medxy.ai/news/cleat-trial-hip-exercise 2026-01-13T13:16:58.000Z daily 0.75 https://www.medxy.ai/news/vi/cycling-comfort-cleat-experiment 2026-01-13T13:26:56.000Z daily 0.75 https://www.medxy.ai/news/ja/bike-relief-cleat-study 2026-01-13T13:27:21.000Z daily 0.75 https://www.medxy.ai/news/zh/cycling-pain-relief 2026-01-13T13:27:37.000Z daily 0.75 https://www.medxy.ai/news/beyond-immunotherapy 2026-01-13T13:22:30.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-immunotherapy-colon-cancer 2026-01-13T13:27:46.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-immunotherapy-colorectal-cancer 2026-01-13T13:28:09.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-traditional-immunotherapy 2026-01-13T13:28:18.000Z daily 0.75 https://www.medxy.ai/news/cognitive-functional-therapy-results 2026-01-13T13:28:52.000Z daily 0.75 https://www.medxy.ai/news/vi/functional-cognitive-therapy-back-pain-results 2026-01-13T13:42:06.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-back-pain-therapy 2026-01-13T13:42:18.000Z daily 0.75 https://www.medxy.ai/news/zh/cognitive-therapy-chronic-back-pain 2026-01-13T13:42:27.000Z daily 0.75 https://www.medxy.ai/news/aggressive-management-psoriatic-arthritis 2026-01-13T13:41:17.000Z daily 0.75 https://www.medxy.ai/news/vi/aggressive-initiation-management-early-butterfly-arthritis 2026-01-13T14:00:04.000Z daily 0.75 https://www.medxy.ai/news/ja/early-psoriatic-arthritis-management-2 2026-01-13T14:00:14.000Z daily 0.75 https://www.medxy.ai/news/zh/early-psoriatic-arthritis-management 2026-01-13T14:00:22.000Z daily 0.75 https://www.medxy.ai/news/baricitinib-efficacy-juve-basis 2026-01-13T14:01:30.000Z daily 0.75 https://www.medxy.ai/news/vi/baricitinib-efficacy-children 2026-01-13T19:31:21.000Z daily 0.75 https://www.medxy.ai/news/ja/serum-proteomics-barisitinib-jia 2026-01-13T19:31:28.000Z daily 0.75 https://www.medxy.ai/news/zh/serum-proteomics-baritinib-efficacy 2026-01-13T19:31:35.000Z daily 0.75 https://www.medxy.ai/news/taladegib-lung-function-ipf 2026-01-13T19:31:07.000Z daily 0.75 https://www.medxy.ai/news/vi/taladegib-ipf-trial-results 2026-01-13T22:05:26.000Z daily 0.75 https://www.medxy.ai/news/ja/taradejibi-ipf-trial-results 2026-01-13T22:05:32.000Z daily 0.75 https://www.medxy.ai/news/zh/taladegib-ipf-lung-function 2026-01-13T22:05:38.000Z daily 0.75 https://www.medxy.ai/news/pembrolizumab-nsclc-challenge 2026-01-13T19:59:44.000Z daily 0.75 https://www.medxy.ai/news/vi/pembrolizumab-non-radiation-nsclc 2026-01-13T22:05:46.000Z daily 0.75 https://www.medxy.ai/news/ja/pemext-chemotherapy-challenge 2026-01-13T22:05:59.000Z daily 0.75 https://www.medxy.ai/news/zh/pembrolizumab-chemo-challenge 2026-01-13T22:06:11.000Z daily 0.75 https://www.medxy.ai/news/green-advice-patient-trust 2026-01-13T20:13:27.000Z daily 0.75 https://www.medxy.ai/news/vi/green-medical-advice-impact 2026-01-13T22:06:28.000Z daily 0.75 https://www.medxy.ai/news/ja/green-medical-advice-trust-2 2026-01-13T22:06:33.000Z daily 0.75 https://www.medxy.ai/news/zh/green-medical-advice-trust 2026-01-13T22:06:39.000Z daily 0.75 https://www.medxy.ai/news/factor-xi-inhibition-vte-prevention 2026-01-13T20:21:21.000Z daily 0.75 https://www.medxy.ai/news/vi/redefining-factor-xi-vte-prevention 2026-01-13T22:06:50.000Z daily 0.75 https://www.medxy.ai/news/ja/xi-factor-inhibition-redefined 2026-01-13T22:07:05.000Z daily 0.75 https://www.medxy.ai/news/zh/factor-xi-inhibition-vte-prevention-2 2026-01-13T22:07:17.000Z daily 0.75 https://www.medxy.ai/news/high-dose-insulin-failure 2026-01-13T21:18:31.000Z daily 0.75 https://www.medxy.ai/news/vi/high-dose-insulin-study 2026-01-13T22:07:26.000Z daily 0.75 https://www.medxy.ai/news/zh/high-dose-insulin-failure-2 2026-01-13T22:07:36.000Z daily 0.75 https://www.medxy.ai/news/retifanlimab-chemo-nsclc-survival-2 2026-01-13T22:13:01.000Z daily 0.75 https://www.medxy.ai/news/dual-purpose-health 2026-01-13T22:15:11.000Z daily 0.75 https://www.medxy.ai/news/vi/public-health-ivermectin 2026-01-13T22:18:42.000Z daily 0.75 https://www.medxy.ai/news/ja/public-health-ivermectin-impact 2026-01-13T22:53:41.000Z daily 0.75 https://www.medxy.ai/news/zh/public-health-ivermectin-use 2026-01-13T22:53:48.000Z daily 0.75 https://www.medxy.ai/news/venetoclax-azacitidine-tcell-leukemia 2026-01-13T22:54:07.000Z daily 0.75 https://www.medxy.ai/news/vi/venetoclax-azacitidine-therapy 2026-01-13T22:53:58.000Z daily 0.75 https://www.medxy.ai/news/ja/venetoclax-azacitidine-t-cell-leukemia 2026-01-13T22:54:02.000Z daily 0.75 https://www.medxy.ai/news/zh/vincristine-and-azacitidine-for-relapsed-t-cell-all 2026-01-13T22:54:13.000Z daily 0.75 https://www.medxy.ai/news/model-based-dosing-accelerates-cd4-reconstitution 2026-01-13T22:54:19.000Z daily 0.75 https://www.medxy.ai/news/vi/atg-dosage-cd4-enhancement 2026-01-13T22:54:24.000Z daily 0.75 https://www.medxy.ai/news/ja/atg-dosing-accelerates-cd4-reconstitution 2026-01-13T22:54:32.000Z daily 0.75 https://www.medxy.ai/news/zh/model-based-atg-dosing 2026-01-13T22:54:39.000Z daily 0.75 https://www.medxy.ai/news/nasal-vaccine-whooping-cough 2026-01-13T22:34:42.000Z daily 0.75 https://www.medxy.ai/news/music-interventions-dementia 2026-01-13T22:53:29.000Z daily 0.75 https://www.medxy.ai/news/dual-agonism-pemvidutide 2026-01-13T22:55:27.000Z daily 0.75 https://www.medxy.ai/news/vi/double-stimulation-mash 2026-01-13T23:10:42.000Z daily 0.75 https://www.medxy.ai/news/ja/mash-double-agonist 2026-01-13T23:11:00.000Z daily 0.75 https://www.medxy.ai/news/zh/mash-dual-receptor-against-pemvidutide 2026-01-13T23:11:06.000Z daily 0.75 https://www.medxy.ai/news/pemvidutide-mash-resolution 2026-01-14T09:04:26.000Z daily 0.75 https://www.medxy.ai/news/vi/pemvidutide-mash-trial-results 2026-01-14T09:13:53.000Z daily 0.75 https://www.medxy.ai/news/ja/pemvidutide-impact-trial 2026-01-14T09:14:02.000Z daily 0.75 https://www.medxy.ai/news/zh/pemvidutide-impact-2b-mash 2026-01-14T09:14:16.000Z daily 0.75 https://www.medxy.ai/news/hemodynamic-conservation-vs-obliteration 2026-01-14T10:42:50.000Z daily 0.75 https://www.medxy.ai/news/vi/hemodynamic-conservation-vs-destruction 2026-01-14T10:43:22.000Z daily 0.75 https://www.medxy.ai/news/ja/chiva-hybrid-venous-treatment 2026-01-14T10:43:36.000Z daily 0.75 https://www.medxy.ai/news/zh/hemodynamic-protection-chiva 2026-01-14T10:43:56.000Z daily 0.75 https://www.medxy.ai/news/two-dose-hev-sg-v-regimen 2026-01-14T10:27:53.000Z daily 0.75 https://www.medxy.ai/news/vi/hev-sg-v-trial-nipah 2026-01-14T10:40:20.000Z daily 0.75 https://www.medxy.ai/news/ja/hevs-gv-regimen-nipah-virus 2026-01-14T10:40:27.000Z daily 0.75 https://www.medxy.ai/news/zh/hevs-g-vaccine-nipah-response 2026-01-14T10:40:35.000Z daily 0.75 https://www.medxy.ai/news/pulmonary-embolism-exclusion 2026-01-14T10:37:54.000Z daily 0.75 https://www.medxy.ai/news/vi/simplifying-pulmonary-thromboembolism 2026-01-14T10:40:43.000Z daily 0.75 https://www.medxy.ai/news/ja/pulmonary-embolism-exclusion-2 2026-01-14T10:44:13.000Z daily 0.75 https://www.medxy.ai/news/zh/simplifying-pe-checks 2026-01-14T10:44:21.000Z daily 0.75 https://www.medxy.ai/news/cancer-statistics-2026 2026-01-14T12:45:59.000Z daily 0.75 https://www.medxy.ai/news/atezolizumab-bcg-nmibc-trial 2026-01-09T15:55:48.000Z daily 0.75 https://www.medxy.ai/news/vi/atezolizumab-bcg-non-improving 2026-01-14T13:31:49.000Z daily 0.75 https://www.medxy.ai/news/ja/atezolizumab-bcg-nmibc-trial-2 2026-01-14T13:31:58.000Z daily 0.75 https://www.medxy.ai/news/zh/atezolizumab-bcg-bladder-cancer-2 2026-01-14T13:32:07.000Z daily 0.75 https://www.medxy.ai/news/tinengotinib-cholangiocarcinoma-breakthrough 2026-01-14T12:55:57.000Z daily 0.75 https://www.medxy.ai/news/vi/tinengotinib-cholangiocarcinoma-fgfr-inhibitor 2026-01-14T13:32:15.000Z daily 0.75 https://www.medxy.ai/news/ja/chinogochinib-fgfr-resistance-treatment 2026-01-14T13:32:23.000Z daily 0.75 https://www.medxy.ai/news/zh/tinengotinib-fgfr-resistance 2026-01-14T13:32:31.000Z daily 0.75 https://www.medxy.ai/news/targeted-bone-support 2026-01-14T13:30:16.000Z daily 0.75 https://www.medxy.ai/news/vi/bone-health-support 2026-01-14T13:49:47.000Z daily 0.75 https://www.medxy.ai/news/ja/bone-support-hiv-youth 2026-01-14T13:49:54.000Z daily 0.75 https://www.medxy.ai/news/zh/targeting-bone-support 2026-01-14T13:49:59.000Z daily 0.75 https://www.medxy.ai/news/camrelizumab-capecitabine-cholangiocarcinoma 2026-01-14T13:35:15.000Z daily 0.75 https://www.medxy.ai/news/vi/camrelizumab-capecitabine-biliary-cancer 2026-01-14T13:50:07.000Z daily 0.75 https://www.medxy.ai/news/ja/kamrelizumab-capecitabine-combination 2026-01-14T13:50:14.000Z daily 0.75 https://www.medxy.ai/news/zh/improvement-in-survival-hcc 2026-01-14T13:50:22.000Z daily 0.75 https://www.medxy.ai/news/global-gastro-cancer-burden-2050 2026-01-14T13:40:58.000Z daily 0.75 https://www.medxy.ai/news/vi/global-gastrointestinal-cancer-burden 2026-01-14T13:50:29.000Z daily 0.75 https://www.medxy.ai/news/zh/global-gastrointestinal-cancer-2050 2026-01-14T13:50:43.000Z daily 0.75 https://www.medxy.ai/news/bevacizumab-stereotactic-radiotherapy 2026-01-14T13:49:32.000Z daily 0.75 https://www.medxy.ai/news/vi/bevacizumab-stereotactic-radiation 2026-01-14T15:50:04.000Z daily 0.75 https://www.medxy.ai/news/ja/bevacizumab-stereotactic-radiotherapy-2 2026-01-14T15:50:12.000Z daily 0.75 https://www.medxy.ai/news/zh/bevacizumab-stereotactic-radiotherapy-3 2026-01-14T15:50:21.000Z daily 0.75 https://www.medxy.ai/news/personalizing-neoadjuvant-irino 2026-01-14T15:20:20.000Z daily 0.75 https://www.medxy.ai/news/vi/preoperative-irrinotecan-guidance 2026-01-14T15:50:29.000Z daily 0.75 https://www.medxy.ai/news/ja/individualized-therapy-ugt1a1-irinotecan 2026-01-14T15:50:38.000Z daily 0.75 https://www.medxy.ai/news/zh/personalized-therapy-irinotecan-research 2026-01-14T15:50:43.000Z daily 0.75 https://www.medxy.ai/news/sbrt-cadonilimab-efficacy 2026-01-14T15:30:42.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-resistance-sbrt-cadonilimab 2026-01-14T15:50:52.000Z daily 0.75 https://www.medxy.ai/news/ja/resistance-breakthrough-sbrt-cadinilimab 2026-01-14T15:51:01.000Z daily 0.75 https://www.medxy.ai/news/zh/breakthrough-resistance-sbrt 2026-01-14T15:51:08.000Z daily 0.75 https://www.medxy.ai/news/decadal-leap-tcx-regimen 2026-01-14T15:51:13.000Z daily 0.75 https://www.medxy.ai/news/vi/breakthrough-in-a-decade 2026-01-14T15:51:21.000Z daily 0.75 https://www.medxy.ai/news/ja/10-year-survival-tcx-therapy 2026-01-14T15:51:25.000Z daily 0.75 https://www.medxy.ai/news/zh/ten-year-survival-advantage 2026-01-14T15:51:30.000Z daily 0.75 https://www.medxy.ai/news/serplulimab-chemo-survival 2026-01-14T15:51:36.000Z daily 0.75 https://www.medxy.ai/news/vi/serplulimab-es-sclc-trial 2026-01-14T15:51:40.000Z daily 0.75 https://www.medxy.ai/news/ja/seprolifam-chemo-survival 2026-01-14T15:51:45.000Z daily 0.75 https://www.medxy.ai/news/zh/survival-advantage-astrum-005 2026-01-14T15:58:29.000Z daily 0.75 https://www.medxy.ai/news/cancer-statistics-china 2026-01-14T16:07:34.000Z daily 0.75 https://www.medxy.ai/news/proton-therapy-vs-photons 2026-01-14T16:08:20.000Z daily 0.75 https://www.medxy.ai/news/vi/proton-therapy-vs-photon 2026-01-14T16:32:25.000Z daily 0.75 https://www.medxy.ai/news/ja/proton-therapy-oropharyngeal-cancer 2026-01-14T16:32:35.000Z daily 0.75 https://www.medxy.ai/news/zh/proton-therapy-vs-photon-therapy 2026-01-14T16:32:43.000Z daily 0.75 https://www.medxy.ai/news/epcoritamab-r2-follicular-lymphoma-2 2026-01-14T16:32:51.000Z daily 0.75 https://www.medxy.ai/news/vi/epcoritamab-r2-treatment-standards 2026-01-14T16:32:57.000Z daily 0.75 https://www.medxy.ai/news/ja/epolitamab-r2-follicular-lymphoma 2026-01-14T16:33:17.000Z daily 0.75 https://www.medxy.ai/news/tafasi-r2-benchmark-follicular-lymphoma 2026-01-14T16:33:05.000Z daily 0.75 https://www.medxy.ai/news/zh/epcoritamab-r2-follicular-lymphoma 2026-01-14T16:43:26.000Z daily 0.75 https://www.medxy.ai/news/vi/taf-sitamab-r2-benchmark 2026-01-14T16:43:56.000Z daily 0.75 https://www.medxy.ai/news/ja/tafashitamab-r2-lymphoma-insights 2026-01-14T16:44:03.000Z daily 0.75 https://www.medxy.ai/news/zh/tafasisitamab-r2-follicular-lymphoma 2026-01-14T16:44:12.000Z daily 0.75 https://www.medxy.ai/news/car-t-therapy-anemia 2026-01-14T16:30:04.000Z daily 0.75 https://www.medxy.ai/news/distinct-histological-patterns-anal-canal-cancer 2026-01-14T16:45:06.000Z daily 0.75 https://www.medxy.ai/news/vi/different-organizational-models-rectal-cancer 2026-01-14T17:04:40.000Z daily 0.75 https://www.medxy.ai/news/ja/anal-canal-cancer-pathology-insights 2026-01-14T17:04:50.000Z daily 0.75 https://www.medxy.ai/news/zh/anal-cancer-types 2026-01-14T17:04:58.000Z daily 0.75 https://www.medxy.ai/news/prostate-cancer-2025-2 2026-01-14T17:05:05.000Z daily 0.75 https://www.medxy.ai/news/vi/prostate-cancer-2025 2026-01-14T17:05:13.000Z daily 0.75 https://www.medxy.ai/news/zh/prostate-cancer-statistics-2025 2026-01-14T17:05:28.000Z daily 0.75 https://www.medxy.ai/news/iberdomide-triple-therapy-2 2026-01-14T17:05:36.000Z daily 0.75 https://www.medxy.ai/news/vi/iberdomide-triple-therapy-3 2026-01-14T17:05:41.000Z daily 0.75 https://www.medxy.ai/news/ja/iberdomide-triple-therapy 2026-01-14T17:05:48.000Z daily 0.75 https://www.medxy.ai/news/zh/iberdomide-triple-therapy-4 2026-01-14T17:07:20.000Z daily 0.75 https://www.medxy.ai/news/intravenous-iron-pregnancy-care 2026-01-14T17:07:38.000Z daily 0.75 https://www.medxy.ai/news/fremanezumab-pediatric-migraine 2026-01-14T20:33:20.000Z daily 0.75 https://www.medxy.ai/news/vi/fremanezumab-migraine-prevention-children 2026-01-14T20:30:46.000Z daily 0.75 https://www.medxy.ai/news/ja/frimanizumab-pediatric-migraine 2026-01-14T20:30:56.000Z daily 0.75 https://www.medxy.ai/news/zh/fremanezumab-children-migraine-prevention 2026-01-14T20:31:19.000Z daily 0.75 https://www.medxy.ai/news/high-peep-recruitment-failure 2026-01-14T20:32:28.000Z daily 0.75 https://www.medxy.ai/news/vi/high-peep-pressure 2026-01-14T20:32:39.000Z daily 0.75 https://www.medxy.ai/news/ja/high-peep-no-effect 2026-01-14T20:35:17.000Z daily 0.75 https://www.medxy.ai/news/zh/high-peep-lung-recruitment-failed 2026-01-14T20:35:24.000Z daily 0.75 https://www.medxy.ai/news/bictegravir-tb-therapy 2026-01-14T20:35:38.000Z daily 0.75 https://www.medxy.ai/news/vi/bictegravir-tb-rifampicin 2026-01-16T16:36:48.000Z daily 0.75 https://www.medxy.ai/news/ja/rifapentine-tb-treatment-insight 2026-01-16T16:36:57.000Z daily 0.75 https://www.medxy.ai/news/zh/daily-biktarvy-treatment 2026-01-16T16:37:01.000Z daily 0.75 https://www.medxy.ai/news/epcoritamab-richter-transformation-2 2026-01-16T16:37:20.000Z daily 0.75 https://www.medxy.ai/news/vi/epcoritamab-tumor-activity-2 2026-01-16T16:37:25.000Z daily 0.75 https://www.medxy.ai/news/ja/epolitamab-therapy-insights 2026-01-16T16:37:28.000Z daily 0.75 https://www.medxy.ai/news/zh/epcoritamab-tumor-activity 2026-01-16T16:37:33.000Z daily 0.75 https://www.medxy.ai/news/semaglutide-weight-loss-asian-adults 2026-01-15T23:08:00.000Z daily 0.75 https://www.medxy.ai/news/vi/semaglutide-weight-loss-2 2026-01-16T16:37:43.000Z daily 0.75 https://www.medxy.ai/news/ja/semaglutide-weight-loss-asian-adults-2 2026-01-16T16:37:51.000Z daily 0.75 https://www.medxy.ai/news/zh/weekly-semaglutide-16-weight-loss 2026-01-16T16:37:58.000Z daily 0.75 https://www.medxy.ai/news/ai-decision-support-antibiotics 2026-01-15T23:13:47.000Z daily 0.75 https://www.medxy.ai/news/vi/ai-antibiotic-decision-support 2026-01-16T16:38:04.000Z daily 0.75 https://www.medxy.ai/news/ja/antibiotic-switching-aid 2026-01-16T16:38:10.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-driven-antibiotic-decision-support 2026-01-16T16:38:14.000Z daily 0.75 https://www.medxy.ai/news/mailed-self-collection-kits 2026-01-16T07:50:47.000Z daily 0.75 https://www.medxy.ai/news/vi/at-home-sampling-kit 2026-01-16T16:39:14.000Z daily 0.75 https://www.medxy.ai/news/ja/self-collection-kit 2026-01-16T16:39:25.000Z daily 0.75 https://www.medxy.ai/news/zh/self-sampling-kit-cervical-cancer-screening 2026-01-16T16:39:36.000Z daily 0.75 https://www.medxy.ai/news/opportunistic-genomic-screening 2026-01-16T13:25:17.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-screening-fh 2026-01-16T16:40:16.000Z daily 0.75 https://www.medxy.ai/news/ja/familial-hypercholesterolemia-genome-screening 2026-01-16T16:40:24.000Z daily 0.75 https://www.medxy.ai/news/zh/familial-hypercholesterolemia-genetic-screening 2026-01-16T16:40:31.000Z daily 0.75 https://www.medxy.ai/news/beyond-hospital-walls 2026-01-16T15:30:38.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-hospital-walls-antibiotic-challenges 2026-01-16T16:40:46.000Z daily 0.75 https://www.medxy.ai/news/ja/ward-boundary-breakthrough 2026-01-16T16:40:53.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-hospital-walls-2 2026-01-16T16:41:04.000Z daily 0.75 https://www.medxy.ai/news/metformin-betamethasone-glycemic-dysregulation 2026-01-16T16:31:34.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-hypoglycemia-reduction 2026-01-16T16:42:14.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-betamethasone-blood-sugar 2026-01-16T16:42:21.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-reduces-glucocorticoid-diabetes 2026-01-16T16:42:29.000Z daily 0.75 https://www.medxy.ai/news/graded-sensorimotor-retraining 2026-01-16T16:36:21.000Z daily 0.75 https://www.medxy.ai/news/vi/movement-sensory-training-back-pain 2026-01-16T16:42:41.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-low-back-pain-retraining-2 2026-01-16T16:42:50.000Z daily 0.75 https://www.medxy.ai/news/zh/chronic-low-back-pain-retraining 2026-01-16T16:42:59.000Z daily 0.75 https://www.medxy.ai/news/electronic-patient-interventions-benzodiazepine-cessation 2026-01-16T16:44:08.000Z daily 0.75 https://www.medxy.ai/news/vi/success-and-electronic-intervention 2026-01-16T16:53:09.000Z daily 0.75 https://www.medxy.ai/news/ja/scalable-success-benzodiazepine-withdrawal 2026-01-16T16:53:24.000Z daily 0.75 https://www.medxy.ai/news/zh/expandable-success-benzodiazepine-discontinuation 2026-01-16T16:53:34.000Z daily 0.75 https://www.medxy.ai/news/40-hz-light-stimulation 2026-01-16T16:54:08.000Z daily 0.75 https://www.medxy.ai/news/vi/40hz-light-stimulation-post-surgery 2026-01-16T17:09:20.000Z daily 0.75 https://www.medxy.ai/news/ja/40hz-light-stimulation 2026-01-16T17:09:27.000Z daily 0.75 https://www.medxy.ai/news/zh/40hz-light-stimulation-dreduces-delirium 2026-01-16T17:09:32.000Z daily 0.75 https://www.medxy.ai/news/risk-stratified-blood-pressure-management 2026-01-16T17:00:10.000Z daily 0.75 https://www.medxy.ai/news/individualized-blood-pressure-targets 2026-01-16T23:42:59.000Z daily 0.75 https://www.medxy.ai/news/vi/personalized-blood-pressure-goals 2026-01-16T23:42:40.000Z daily 0.75 https://www.medxy.ai/news/ja/individualized-blood-pressure-targets-2 2026-01-16T23:42:19.000Z daily 0.75 https://www.medxy.ai/news/zh/personalized-blood-pressure-goals-2 2026-01-16T23:42:04.000Z daily 0.75 https://www.medxy.ai/news/early-antipsychotic-dose-reduction 2026-01-16T17:11:07.000Z daily 0.75 https://www.medxy.ai/news/vi/dose-reduction-benefits 2026-01-16T23:41:51.000Z daily 0.75 https://www.medxy.ai/news/ja/balance-in-dosing 2026-01-16T23:41:42.000Z daily 0.75 https://www.medxy.ai/news/zh/balance-in-antipsychotics 2026-01-16T23:41:37.000Z daily 0.75 https://www.medxy.ai/news/tenecteplase-vs-alteplase 2026-01-16T17:19:21.000Z daily 0.75 https://www.medxy.ai/news/vi/tenecteplase-vs-alteplase-2 2026-01-16T23:41:17.000Z daily 0.75 https://www.medxy.ai/news/ja/tenet-insights 2026-01-16T23:41:12.000Z daily 0.75 https://www.medxy.ai/news/zh/rnap-therapy-tenet-trial 2026-01-16T23:41:01.000Z daily 0.75 https://www.medxy.ai/news/interleukin-6-inhibition 2026-01-16T17:25:27.000Z daily 0.75 https://www.medxy.ai/news/vi/inhibition-interleukin-6 2026-01-16T23:40:50.000Z daily 0.75 https://www.medxy.ai/news/ja/interleukin-6-inhibition-2 2026-01-16T23:40:37.000Z daily 0.75 https://www.medxy.ai/news/zh/il-6-inhibition-reducing-risk 2026-01-16T23:40:27.000Z daily 0.75 https://www.medxy.ai/news/digital-storytelling-influenza-vaccination 2026-01-16T17:31:28.000Z daily 0.75 https://www.medxy.ai/news/vi/digital-story-boosts-flu-vaccination 2026-01-16T23:40:15.000Z daily 0.75 https://www.medxy.ai/news/ja/digital-storytelling-influenza-vaccination-2 2026-01-16T23:40:00.000Z daily 0.75 https://www.medxy.ai/news/zh/digital-storytelling-pediatric-flu-vaccine 2026-01-16T23:39:52.000Z daily 0.75 https://www.medxy.ai/news/act-parenting-interventions 2026-01-16T18:03:52.000Z daily 0.75 https://www.medxy.ai/news/vi/act-interventions-caregivers-autism 2026-01-16T23:39:44.000Z daily 0.75 https://www.medxy.ai/news/ja/act-parent-intervention-stress-reduction 2026-01-16T23:39:32.000Z daily 0.75 https://www.medxy.ai/news/zh/parenting-intervention-autism 2026-01-16T23:39:22.000Z daily 0.75 https://www.medxy.ai/news/ethosuximide-ibs-pain-trial 2026-01-16T19:45:23.000Z daily 0.75 https://www.medxy.ai/news/vi/ethosuximide-abdominal-pain 2026-01-16T23:39:10.000Z daily 0.75 https://www.medxy.ai/news/ja/etiosuximide-ibs-pain-study 2026-01-16T23:39:01.000Z daily 0.75 https://www.medxy.ai/news/zh/butyrophenone-ibs-pain-trial 2026-01-16T23:38:52.000Z daily 0.75 https://www.medxy.ai/news/atherectomy-fails-best-cli 2026-01-16T20:46:20.000Z daily 0.75 https://www.medxy.ai/news/vi/atherectomy-is-no-improvement 2026-01-16T23:38:36.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-ischemia-aterectomy-analysis 2026-01-16T23:38:28.000Z daily 0.75 https://www.medxy.ai/news/zh/plaque-excision-failure 2026-01-16T23:38:19.000Z daily 0.75 https://www.medxy.ai/news/intensive-blood-pressure-control 2026-01-16T21:16:42.000Z daily 0.75 https://www.medxy.ai/news/vi/strong-blood-pressure-control 2026-01-16T23:37:57.000Z daily 0.75 https://www.medxy.ai/news/ja/systolic-blood-pressure-management 2026-01-16T23:37:48.000Z daily 0.75 https://www.medxy.ai/news/zh/blood-pressure-control-benefits 2026-01-16T23:37:41.000Z daily 0.75 https://www.medxy.ai/news/sex-specific-phenotypes-aldose-reductase 2026-01-16T21:26:12.000Z daily 0.75 https://www.medxy.ai/news/vi/phenotype-gender-diabetes-cardiovascular 2026-01-16T23:37:20.000Z daily 0.75 https://www.medxy.ai/news/zh/diabetic-cardiomyopathy-gender-phenotypes 2026-01-16T23:37:12.000Z daily 0.75 https://www.medxy.ai/news/finerenone-heart-failure-protection 2026-01-16T21:59:22.000Z daily 0.75 https://www.medxy.ai/news/vi/finerenone-heart-failure-protection-3 2026-01-16T23:36:26.000Z daily 0.75 https://www.medxy.ai/news/ja/finerenone-heart-failure-protection-2 2026-01-16T23:36:17.000Z daily 0.75 https://www.medxy.ai/news/zh/fedinaphrone-heart-failure-protection 2026-01-16T23:36:09.000Z daily 0.75 https://www.medxy.ai/news/finerenone-cardiorenal-protection 2026-01-16T23:35:13.000Z daily 0.75 https://www.medxy.ai/news/vi/finerenone-heart-kidney-protection 2026-01-16T23:44:37.000Z daily 0.75